|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q37830227
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000314.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q37830227
|
|
024
|
|
|
‡a
0000-0001-9895-503X
‡2
orcid
|
|
024
|
|
|
‡a
25822248900
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q37830227
|
|
100
|
0 |
|
‡a
Maria de Lourdes Bastos
‡c
investigadora
‡9
ast
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Maria de Lourdes Bastos
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Maria de Lourdes Bastos
‡c
investigadora
‡9
es
|
|
400
|
0 |
|
‡a
Maria De Lourdes Bastos
‡c
ricercatrice
‡9
it
|
|
400
|
0 |
|
‡a
Maria de Lourdes Bastos
‡c
wetenschapper
‡9
nl
|
|
400
|
0 |
|
‡a
Maria de Lourdes Bastos
‡c
investigadora
‡9
pt
|
|
670
|
|
|
‡a
Author's 2-styrylchromones as novel inhibitors of xanthine oxidase. A structure-activity study
|
|
670
|
|
|
‡a
Author's 3,4-Methylenedioxymethamphetamine Hepatotoxicity under the Heat Stress Condition: Novel Insights from in Vitro Metabolomic Studies
|
|
670
|
|
|
‡a
Author's 3,4-Methylenedioxypyrovalerone (MDPV): in vitro mechanisms of hepatotoxicity under normothermic and hyperthermic conditions.
|
|
670
|
|
|
‡a
Author's 4-Methylthioamphetamine-induced hyperthermia in mice: influence of serotonergic and catecholaminergic pathways
|
|
670
|
|
|
‡a
Author's 5,7-Dihydroxitryptamine toxicity to serotonergic neurons in serum free raphe cultures
|
|
670
|
|
|
‡a
Author's A breakthrough on Amanita phalloides poisoning: an effective antidotal effect by polymyxin B.
|
|
670
|
|
|
‡a
Author's A GC/MS method for measuring cocaine metabolism in human renal cells
|
|
670
|
|
|
‡a
Author's A Metabolomic Approach for the In Vivo Study of Gold Nanospheres and Nanostars after a Single-Dose Intravenous Administration to Wistar Rats
|
|
670
|
|
|
‡a
Author's A multiparametric study of gold nanoparticles cytotoxicity, internalization and permeability using an in vitro model of blood-brain barrier. Influence of size, shape and capping agent
|
|
670
|
|
|
‡a
Author's A new and vital antidotal pathway for paraquat poisonings more than 60 years later: Induction of lung P-glycoprotein
|
|
670
|
|
|
‡a
Author's A Panel of Urinary Volatile Biomarkers for Differential Diagnosis of Prostate Cancer from Other Urological Cancers
|
|
670
|
|
|
‡a
Author's A rapid and simple procedure for the establishment of human normal and cancer renal primary cell cultures from surgical specimens.
|
|
670
|
|
|
‡a
Author's Acute Paraquat Poisoning
|
|
670
|
|
|
‡a
Author's Adaptative response of antioxidant enzymes in different areas of rat brain after repeated d-amphetamine administration
|
|
670
|
|
|
‡a
Author's Administration of tourniquet. I. Are edema and oxidative stress related to each other and to the duration of ischemia in reperfused skeletal muscle?
|
|
670
|
|
|
‡a
Author's Adrenaline and reactive oxygen species elicit proteome and energetic metabolism modifications in freshly isolated rat cardiomyocytes
|
|
670
|
|
|
‡a
Author's Adrenaline in pro-oxidant conditions elicits intracellular survival pathways in isolated rat cardiomyocytes
|
|
670
|
|
|
‡a
Author's Adverse outcome pathways induced by 3,4-dimethylmethcathinone and 4-methylmethcathinone in differentiated human SH-SY5Y neuronal cells
|
|
670
|
|
|
‡a
Author's Aged rats are more vulnerable than adolescents to “ecstasy” -induced toxicity
|
|
670
|
|
|
‡a
Author's Amanita phalloides poisoning: Mechanisms of toxicity and treatment
|
|
670
|
|
|
‡a
Author's Amphetamine and its metabolite 4-hydroxyamphetamine neurotoxicity in differentiated SH-SY5Y neurons
|
|
670
|
|
|
‡a
Author's An effective antidotal combination of polymyxin B and methylprednisolone for α-amanitin intoxication
|
|
670
|
|
|
‡a
Author's An effective antidote for paraquat poisonings: the treatment with lysine acetylsalicylate
|
|
670
|
|
|
‡a
Author's An insight into the mechanisms underlying the hepatotoxicity of cathinone derivatives
|
|
670
|
|
|
‡a
Author's Analysis of extracellular metabolome by HS-SPME/GC-MS: Optimization and application in a pilot study to evaluate galactosamine-induced hepatotoxicity
|
|
670
|
|
|
‡a
Author's Analysis of volatile human urinary metabolome by solid-phase microextraction in combination with gas chromatography–mass spectrometry for biomarker discovery: Application in a pilot study to discriminate patients with renal cell carcinoma
|
|
670
|
|
|
‡a
Author's Analytical investigation of legal high products containing Salvia divinorum traded in smartshops and internet
|
|
670
|
|
|
‡a
Author's Antioxidant activity of Hypericum androsaemum infusion: scavenging activity against superoxide radical, hydroxyl radical and hypochlorous acid
|
|
670
|
|
|
‡a
Author's Antioxidant properties and associated mechanisms of salicylates.
|
|
670
|
|
|
‡a
Author's Antioxidative properties of cardoon (Cynara cardunculus L.) infusion against superoxide radical, hydroxyl radical, and hypochlorous acid
|
|
670
|
|
|
‡a
Author's Assessing combination effects of amphetamine designer drugs
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of 6-phytase produced by <i>Trichoderma reesei</i>CBS 122001 as a feed additive for pigs and poultry, from Roal Oy
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of AveMix®XG 10 (endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase) for chickens for fattening
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of AviPlus® as a feed additive for all porcine species (weaned), chickens for fattening, chickens reared for laying, minor poultry species for fattening, minor poultry species reared for lay
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of Bactocell® (Pediococcus acidilactici CNCM I-4622) as a feed additive for all fish and shrimps and its extension of use for all crustaceans
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of Bactocell® (Pediococcus acidilactici CNCM I-4622) as a feed additive for weaned piglets, pigs for fattening, minor porcine species (weaned and for fattening), chickens for fattening, layi
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of Biosprint® (Saccharomyces cerevisiae MUCL 39885) as a feed additive for weaned piglets
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of Biosprint® (Saccharomyces cerevisiae MUCL 39885) for dairy cows and horses
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of Biosprint® (Saccharomyces cerevisiae MUCL 39885) for sows
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of Biosprint® (Saccharomyces cerevisiae MUCL 39885) as a feed additive for weaned piglets
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of Bonvital® (Enterococcus faecium DSM 7134) as a feed additive for weaned piglets and pigs for fattening
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of Calsporin® (Bacillus subtilis DSM 15544) for chickens for fattening
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of Ecobiol® (Bacillus amyloliquefaciens CECT 5940) as a feed additive for chickens for fattening and its extension of use for chickens reared for laying
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of ECONASE®XT (endo-1,4-β-xylanase) as a feed additive for piglets (weaned), chickens for fattening, chickens reared for laying, turkeys for fattening and turkeys reared for breeding
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of endo-1,4-β-xylanase produced by <i>Aspergillus niger</i>CBS 109.713 and endo-1,4-β-glucanase produced by <i>Aspergillus niger</i>DSM 18404 for poultry species, ornamental birds and weaned
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of Formi™ LHS (potassium diformate) for sows
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of GalliPro® (Bacillus subtilis DSM 17299) for chickens for fattening
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of l-arginine produced by fermentation using Corynebacterium glutamicum NITE SD 00285 for all animal species
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of l-histidine monohydrochloride monohydrate produced with Escherichia coli NITE SD 00268 for salmonids and its extension of use to other fin fish
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of l-isoleucine produced by Escherichia coli FERM ABP-10641 as a nutritional additive, its extension of use in water for drinking and a new use as flavouring additive for all animal species
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of Lantharenol® (lanthanum carbonate octahydrate) for cats
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of Levucell SC (Saccharomyces cerevisiae CNCM I-1077) as a feed additive for lambs and horses
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of manganese chelate of hydroxy analogue of methionine for all animal species
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of Natugrain® Wheat TS and TS L (endo-1,4-beta-xylanase) as a feed additive for chickens for fattening, ducks, turkeys for fattening, turkeys reared for breeding, minor avian species (except
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of PHYZYME®XP 5000 G/L (6-phytase) for chickens for fattening, laying hens, turkeys for fattening, ducks for fattening, weaned piglets, pigs for fattening and sows for reproduction
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of pyridoxine hydrochloride (vitamin B6) as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of selenomethionine produced by Saccharomyces cerevisiae CNCM I-3060 (selenised yeast inactivated) for all animal species
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of selenomethionine produced by Saccharomyces cerevisiae NCYC R397 for all animal species
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of VevoVitall® (benzoic acid) as feed additive for weaned piglets and pigs for fattening
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of Yea-Sacc® (Saccharomyces cerevisiae) for horses
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of authorisation of zinc chelate of hydroxy analogue of methionine for all animal species
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of the authorisation of Actisaf® Sc 47 (Saccharomyces cerevisiae CNCM I-4407) as a feed additive for calves for rearing
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of the authorisation of Amaferm® (fermentation product of Aspergillus oryzae NRRL 458) as a feed additive for dairy cows
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of the authorisation of Calsporin® (Bacillus velezensisDSM 15544) as a feed additive for weaned piglets
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of the authorisation of Calsporin® (Bacillus velezensisDSM 15544) as a feed additive for weaned piglets
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of the authorisation of Natuphos (3-phytase) as a feed additive for poultry and pigs
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of the authorisation of Pediococcus pentosaceus DSM 16244 as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Assessment of the application for renewal of the authorisation of PHYZYME®XP 10000 TPT/L (6-phytase) as a feed additive for all avian species and all swine species
|
|
670
|
|
|
‡a
Author's Association of Tuberculosis Status with Neurologic Disease and Immune Response in HTLV-1 Infection.
|
|
670
|
|
|
‡a
Author's Benzo fury: A new trend in the drug misuse scene
|
|
670
|
|
|
‡a
Author's Benzodiazepine stability in postmortem samples stored at different temperatures.
|
|
670
|
|
|
‡a
Author's Bioavailability of residues of diazepam and its metabolites
|
|
670
|
|
|
‡a
Author's Biodistribution and metabolic profile of 3,4-dimethylmethcathinone (3,4-DMMC) in Wistar rats through gas chromatography-mass spectrometry (GC-MS) analysis
|
|
670
|
|
|
‡a
Author's Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studies
|
|
670
|
|
|
‡a
Author's Biomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems
|
|
670
|
|
|
‡a
Author's Biomarkers in renal cell carcinoma: a metabolomics approach
|
|
670
|
|
|
‡a
Author's CARDIOTOXICITY STUDIES USING FRESHLY ISOLATED CALCIUM-TOLERANT CARDIOMYOCYTES FROM ADULT RAT
|
|
670
|
|
|
‡a
Author's Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP.
|
|
670
|
|
|
‡a
Author's Cellular uptake and toxicity on two distinct hepatic cell models
|
|
670
|
|
|
‡a
Author's Changes in taurine levels in response to repeated administration of the beta2-agonist salbutamol in lambs
|
|
670
|
|
|
‡a
Author's Characterization of chemical compounds susceptible to be extracted from cork by the wine using GC-MS and 1H NMR metabolomic approaches
|
|
670
|
|
|
‡a
Author's Chemical characterization and in vitro cyto- and genotoxicity of ‘legal high’ products containing Kratom
|
|
670
|
|
|
‡a
Author's Chemical characterization and in vitro cyto- and genotoxicity of ‘legal high’ products containing Kratom (Mitragyna speciosa)
|
|
670
|
|
|
‡a
Author's Chemical reactivity of paraquat with the previously validated antidote, sodium salicylate
|
|
670
|
|
|
‡a
Author's Chromatographic Methodologies for Analysis of Cocaine and Its Metabolites in Biological Matrices
|
|
670
|
|
|
‡a
Author's Chromium Speciation Analysis in Bread Samples
|
|
670
|
|
|
‡a
Author's Chromium speciation and biochemical changes vary in relation to plant ploidy
|
|
670
|
|
|
‡a
Author's Chronic exposure to ethanol exacerbates MDMA-induced hyperthermia and exposes liver to severe MDMA-induced toxicity in CD1 mice
|
|
670
|
|
|
‡a
Author's Clinical and forensic signs related to chemical burns: a mechanistic approach
|
|
670
|
|
|
‡a
Author's Co-ingestion of amatoxins and isoxazoles-containing mushrooms and successful treatment: A case report
|
|
670
|
|
|
‡a
Author's Cocaine-induced kidney toxicity: an in vitro study using primary cultured human proximal tubular epithelial cells
|
|
670
|
|
|
‡a
Author's Colchicine effect on P-glycoprotein expression and activity: In silico and in vitro studies
|
|
670
|
|
|
‡a
Author's Comparative effects of 3,4-methylenedioxymethamphetamine and 4-methylthioamphetamine on rat liver mitochondrial function.
|
|
670
|
|
|
‡a
Author's Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouse.
|
|
670
|
|
|
‡a
Author's Contribution of catecholamine reactive intermediates and oxidative stress to the pathologic features of heart diseases
|
|
670
|
|
|
‡a
Author's Contribution of oxidative metabolism to cocaine-induced liver and kidney damage
|
|
670
|
|
|
‡a
Author's Copper enhances isoproterenol toxicity in isolated rat cardiomyocytes: effects on oxidative stress
|
|
670
|
|
|
‡a
Author's Correction to: In vitro mechanistic studies on α-amanitin and its putative antidotes
|
|
670
|
|
|
‡a
Author's Corrigendum to 'P-Glycoprotein activation by 1-(propan-2-ylamino)-4-propoxy-9H-thioxanthen-9-one (TX5) in rat distal ileum: Ex vivo and in vivo studies' [Toxicology and Applied Pharmacology 386 (2020) 114832]
|
|
670
|
|
|
‡a
Author's Cu2+-induced isoproterenol oxidation into isoprenochrome in adult rat calcium-tolerant cardiomyocytes
|
|
670
|
|
|
‡a
Author's Cumulative mitoxantrone-induced haematological and hepatic adverse effects in a subchronic in vivo study
|
|
670
|
|
|
‡a
Author's CYP2D6 increases toxicity of the designer drug 4-methylthioamphetamine (4-MTA)
|
|
670
|
|
|
‡a
Author's Cytotoxicity and cell signalling induced by continuous mild hyperthermia in freshly isolated mouse hepatocytes
|
|
670
|
|
|
‡a
Author's Cytotoxicity of gold and silver nanoparticles in the Caco-2 human intestinal epithelial cell line
|
|
670
|
|
|
‡a
Author's d-Amphetamine-induced hepatotoxicity: possible contribution of catecholamines and hyperthermia to the effect studied in isolated rat hepatocytes.
|
|
670
|
|
|
‡a
Author's D-amphetamine-induced hydrogen peroxide production in skeletal muscle is modulated by monoamine oxidase inhibition
|
|
670
|
|
|
‡a
Author's d-Amphetamine Interaction with Glutathione in Freshly Isolated Rat Hepatocytes
|
|
670
|
|
|
‡a
Author's Depletion of total non-protein sulphydryl groups in mouse tissues after administration of d-amphetamine
|
|
670
|
|
|
‡a
Author's Determination of amatoxins and phallotoxins in Amanita phalloides mushrooms from northeastern Portugal by HPLC-DAD-MS.
|
|
670
|
|
|
‡a
Author's Determination of amphetamine and its metabolite p-hydroxyamphetamine in rat urine by reversed-phase high-performance liquid chromatography after dabsyl derivatization.
|
|
670
|
|
|
‡a
Author's Determination of arsenic, cadmium and lead in porcine and bovine kidneys by electrothermal atomic absorption spectrometry
|
|
670
|
|
|
‡a
Author's Development and validation of a gas chromatography/ion trap-mass spectrometry method for simultaneous quantification of cocaine and its metabolites benzoylecgonine and norcocaine: application to the study of cocaine metabolism in human primary cultu
|
|
670
|
|
|
‡a
Author's Development and validation of a GC/IT-MS method for simultaneous quantitation of para and meta-synephrine in biological samples
|
|
670
|
|
|
‡a
Author's Development of headspace–SPME-GC/MS methodology for analysis of volatile urinary metabolites in patients with renal cell carcinoma: A metabolomic approach
|
|
670
|
|
|
‡a
Author's Development of novel rifampicin-derived P-glycoprotein activators/inducers. synthesis, in silico analysis and application in the RBE4 cell model, using paraquat as substrate
|
|
670
|
|
|
‡a
Author's Dexamethasone treatment decreases the pathological effects and increases the survival rate of paraquat-intoxicated rats
|
|
670
|
|
|
‡a
Author's Diet aid or aid to die: an update on 2,4-dinitrophenol (2,4-DNP) use as a weight-loss product
|
|
670
|
|
|
‡a
Author's Differential Effects of Methyl-4-Phenylpyridinium Ion, Rotenone, and Paraquat on Differentiated SH-SY5Y Cells
|
|
670
|
|
|
‡a
Author's Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS.
|
|
670
|
|
|
‡a
Author's Do invading leucocytes contribute to the decrease in glutathione concentrations indicating oxidative stress in exercised muscle, or are they important for its recovery?
|
|
670
|
|
|
‡a
Author's Doxorubicin decreases paraquat accumulation and toxicity in Caco-2 cells
|
|
670
|
|
|
‡a
Author's Doxorubicin induces apoptosis and necrosis in rat cortical neurons through a concentration-biphasic manner
|
|
670
|
|
|
‡a
Author's Doxorubicin induces biphasic neurotoxicity to rat cortical neurons
|
|
670
|
|
|
‡a
Author's Doxorubicin Is Key for the Cardiotoxicity of FAC
|
|
670
|
|
|
‡a
Author's Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells
|
|
670
|
|
|
‡a
Author's Drinking to death: Hyponatraemia induced by synthetic phenethylamines
|
|
670
|
|
|
‡a
Author's ‘Ecstasy’ and amphetamine neurotoxicity to cultured rat cortical neurons in a continuous exposure model
|
|
670
|
|
|
‡a
Author's “Ecstasy” impairs mitochondrial trafficking in hippocampal neurons by a Tau phosphorylation-dependent mechanism involving GSK3β
|
|
670
|
|
|
‡a
Author's Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
|
|
670
|
|
|
‡a
Author's "Ecstasy" -induced toxicity in SH-SY5Y differentiated cells: role of hyperthermia and metabolites.
|
|
670
|
|
|
‡a
Author's Ecstasy induces apoptosis via 5-HT
|
|
670
|
|
|
‡a
Author's Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons
|
|
670
|
|
|
‡a
Author's "Ecstasy" toxicity to adolescent rats following an acute low binge dose
|
|
670
|
|
|
‡a
Author's Editor's Highlight: Characterization of Hepatotoxicity Mechanisms Triggered by Designer Cathinone Drugs
|
|
670
|
|
|
‡a
Author's Editor's Highlight: Characterization of Hepatotoxicity Mechanisms Triggered by Designer Cathinone Drugs (β-Keto Amphetamines).
|
|
670
|
|
|
‡a
Author's Effect of 3,4-methylenedioxyamphetamine on dendritic spine dynamics in rat neocortical neurons--involvement of heat shock protein 27.
|
|
670
|
|
|
‡a
Author's Effect of 3,4-methylenedioxymethamphetamine ( "ecstasy" ) on body temperature and liver antioxidant status in mice: influence of ambient temperature
|
|
670
|
|
|
‡a
Author's Effect of chronic ethanol exposure on the hepatotoxicity of ecstasy in mice: an ex vivo study.
|
|
670
|
|
|
‡a
Author's Effect of surface coating on the biodistribution profile of gold nanoparticles in the rat.
|
|
670
|
|
|
‡a
Author's Effect of temperature on 3,4-methylenedioxypyrovalerone (MDPV)-induced metabolome disruption in primary mouse hepatic cells
|
|
670
|
|
|
‡a
Author's Efficacy of a preparation of algae interspaced bentonite as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Efficacy of Bacillus subtilis DSM 28343 as a zootechnical additive (gut flora stabiliser) for calves for rearing
|
|
670
|
|
|
‡a
Author's Efficacy of calcium formate as a technological feed additive (preservative) for all animal species
|
|
670
|
|
|
‡a
Author's Efficacy of Cygro® 10G (maduramicin ammonium-α) for turkeys
|
|
670
|
|
|
‡a
Author's Efficacy of EB15 10 (Bacillus subtilis DSM 25841) as a feed additive for weaned piglets and weaned minor porcine species
|
|
670
|
|
|
‡a
Author's Efficacy of iron chelates of lysine and glutamic acid as feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Efficacy of Levucell® SB
|
|
670
|
|
|
‡a
Author's Efficacy of Levucell® SB (Saccharomyces cerevisiae CNCM I‐1079) as a feed additive for weaned piglets
|
|
670
|
|
|
‡a
Author's Efficacy of Liderfeed®
|
|
670
|
|
|
‡a
Author's Efficacy of Liderfeed® (eugenol) for chickens for fattening
|
|
670
|
|
|
‡a
Author's Efficacy of methyl ester of conjugated linoleic acid (t10,c12 isomer) for sows and cows for reproduction
|
|
670
|
|
|
‡a
Author's Efficacy of RONOZYME®WX (endo-1,4-β-xylanase) as a feed additive for laying hens
|
|
670
|
|
|
‡a
Author's Efficacy of Saccharomyces cerevisiae (NBRC 0203), Lactobacillus plantarum (NBRC 3070) and Lactobacillus casei (NBRC 3425) as a silage additive for all species
|
|
670
|
|
|
‡a
Author's Efficacy of Saccharomyces cerevisiae NBRC 0203, Lactobacillus plantarum NBRC 3070 and Lactobacillus casei NBRC 3425 as a technological additive (silage additive) for all animal species
|
|
670
|
|
|
‡a
Author's Efficacy of sodium formate as a technological feed additive (hygiene condition enhancer) for all animal species
|
|
670
|
|
|
‡a
Author's Efficacy of ZM16 10 (Bacillus amyloliquefaciens DSM 25840) as a feed additive for weaned piglets and minor porcine species
|
|
670
|
|
|
‡a
Author's Electrospray tandem mass spectrometry of aminochromes
|
|
670
|
|
|
‡a
Author's Emerging club drugs: 5-(2-aminopropyl)benzofuran (5-APB) is more toxic than its isomer 6-(2-aminopropyl)benzofuran (6-APB) in hepatocyte cellular models
|
|
670
|
|
|
‡a
Author's Ethanol addictively enhances the in vitro cardiotoxicity of cocaine through oxidative damage, energetic deregulation, and apoptosis
|
|
670
|
|
|
‡a
Author's Ethanol and ecstasy: A dangerous cocktail for the liver?
|
|
670
|
|
|
‡a
Author's Ethanol, the forgotten artifact in cell culture
|
|
670
|
|
|
‡a
Author's Evaluation of GSH adducts of adrenaline in biological samples
|
|
670
|
|
|
‡a
Author's Evaluation of rifampicin and derivatives cytotoxic profile in RBE4 cells
|
|
670
|
|
|
‡a
Author's Evaluation of toxic/protective effects of the essential oil of Salvia officinalis on freshly isolated rat hepatocytes
|
|
670
|
|
|
‡a
Author's First report on Cydonia oblonga Miller anticancer potential: differential antiproliferative effect against human kidney and colon cancer cells
|
|
670
|
|
|
‡a
Author's Full survival of paraquat-exposed rats after treatment with sodium salicylate☆
|
|
670
|
|
|
‡a
Author's Gas chromatography-ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine
|
|
670
|
|
|
‡a
Author's GC-MS-Based Endometabolome Analysis Differentiates Prostate Cancer from Normal Prostate Cells.
|
|
670
|
|
|
‡a
Author's GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
|
|
670
|
|
|
‡a
Author's GC-MS Metabolomics Reveals Distinct Profiles of Low- and High-Grade Bladder Cancer Cultured Cells
|
|
670
|
|
|
‡a
Author's GC-MS metabolomics reveals disturbed metabolic pathways in primary mouse hepatocytes exposed to subtoxic levels of 3,4-methylenedioxymethamphetamine (MDMA)
|
|
670
|
|
|
‡a
Author's GC-MS Method for the Analysis of Thirteen Opioids, Cocaine and Cocaethylene in Whole Blood Based on a Modified Quechers Extraction
|
|
670
|
|
|
‡a
Author's Gold Nanoparticles Induce Oxidative Stress and Apoptosis in Human Kidney Cells
|
|
670
|
|
|
‡a
Author's Guidance on the assessment of the efficacy of feed additives
|
|
670
|
|
|
‡a
Author's Guidance on the assessment of the safety of feed additives for the consumer
|
|
670
|
|
|
‡a
Author's Guidance on the assessment of the safety of feed additives for the environment
|
|
670
|
|
|
‡a
Author's Guidance on the assessment of the safety of feed additives for the target species
|
|
670
|
|
|
‡a
Author's Guidance on the characterisation of microorganisms used as feed additives or as production organisms
|
|
670
|
|
|
‡a
Author's Guidance on the identity, characterisation and conditions of use of feed additives
|
|
670
|
|
|
‡a
Author's Hepatic Metabolic Derangements Triggered by Hyperthermia: An In Vitro Metabolomic Study
|
|
670
|
|
|
‡a
Author's Hepatoprotective activity of polyhydroxylated 2-styrylchromones against tert-butylhydroperoxide induced toxicity in freshly isolated rat hepatocytes.
|
|
670
|
|
|
‡a
Author's Hepatoprotective activity of xanthones and xanthonolignoids against tert-butylhydroperoxide-induced toxicity in isolated rat hepatocytes--comparison with silybin
|
|
670
|
|
|
‡a
Author's Hepatotoxicity of 3,4-methylenedioxyamphetamine and Alpha -methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates
|
|
670
|
|
|
‡a
Author's Hepatotoxicity of piperazine designer drugs: Comparison of different in vitro models
|
|
670
|
|
|
‡a
Author's Hepatotoxicity of piperazine designer drugs: up-regulation of key enzymes of cholesterol and lipid biosynthesis
|
|
670
|
|
|
‡a
Author's Hexavalent chromium as a contaminant of food matrices: Its control in bread samples
|
|
670
|
|
|
‡a
Author's Histological and toxicological evaluation, in rat, of a P-glycoprotein inducer and activator: 1-(propan-2-ylamino)-4-propoxy-9H-thioxanthen-9-one (TX5)
|
|
670
|
|
|
‡a
Author's HTLV-1 infection interferes with immune responses to Mycobacterium tuberculosis antigens
|
|
670
|
|
|
‡a
Author's Hydrogen peroxide production in mouse tissues after acute d-amphetamine administration. Influence of monoamine oxidase inhibition.
|
|
670
|
|
|
‡a
Author's Hydroxyl radical and hypochlorous acid scavenging activity of small centaury
|
|
670
|
|
|
‡a
Author's Hydroxyl radical and hypochlorous acid scavenging activity of small centaury (Centaurium erythraea) infusion. A comparative study with green tea (Camellia sinensis).
|
|
670
|
|
|
‡a
Author's Hypericum androsaemum infusion increases tert-butyl hydroperoxide-induced mice hepatotoxicity in vivo.
|
|
670
|
|
|
‡a
Author's Hyponatremic effect caused by 3,4-methylenedioxymethamphetamine (ecstasy) in rats: The role of metabolic bioactivation
|
|
670
|
|
|
‡a
Author's Identification of 4-methylthioamphetamine and some of its metabolites in mouse urine by GC-MS after acute administration.
|
|
670
|
|
|
‡a
Author's Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine
|
|
670
|
|
|
‡a
Author's Identification of psychoactive substances in “legal highs” marketed in Portugal
|
|
670
|
|
|
‡a
Author's Immortalized rat brain endothelial cells are highly resistant to paraquat toxic effect
|
|
670
|
|
|
‡a
Author's Impaired TNF, IL-1β, and IL-17 production and increased susceptibility to Mycobacterium tuberculosis infection in HTLV-1 infected individuals.
|
|
670
|
|
|
‡a
Author's Implementation of HPLC Methodology for the Quantification of Malondialdehyde in Cell Suspensions and Liver
|
|
670
|
|
|
‡a
Author's In vitro evaluation of the hepatotoxic potential of piperazine designer drugs
|
|
670
|
|
|
‡a
Author's In vitro hepatotoxicity of 'Legal X': the combination of 1-benzylpiperazine (BZP) and 1-(m-trifluoromethylphenyl)piperazine (TFMPP) triggers oxidative stress, mitochondrial impairment and apoptosis.
|
|
670
|
|
|
‡a
Author's In vitro mechanistic studies on α-amanitin and its putative antidotes
|
|
670
|
|
|
‡a
Author's In vitro models for neurotoxicology research
|
|
670
|
|
|
‡a
Author's In vitro neurotoxicity evaluation of piperazine designer drugs in differentiated human neuroblastoma SH-SY5Y cells
|
|
670
|
|
|
‡a
Author's In vitro study of P-glycoprotein induction as an antidotal pathway to prevent cytotoxicity in Caco-2 cells
|
|
670
|
|
|
‡a
Author's In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV)
|
|
670
|
|
|
‡a
Author's In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV)
|
|
670
|
|
|
‡a
Author's Induction and activation of P-glycoprotein by dihydroxylated xanthones protect against the cytotoxicity of the P-glycoprotein substrate paraquat
|
|
670
|
|
|
‡a
Author's Influence of CYP2D6 polymorphism on 3,4-methylenedioxymethamphetamine ('Ecstasy') cytotoxicity
|
|
670
|
|
|
‡a
Author's Influence of CYP2D6 polymorphism on the cytotoxicity of the designer drug 4-methylthioamphetamine
|
|
670
|
|
|
‡a
Author's Influence of CYP2D6 polymorphism on the cytotoxicity of the designer drug 4-methylthioamphetamine (4-MTA)
|
|
670
|
|
|
‡a
Author's Influence of HTLV-1 on the clinical, microbiologic and immunologic presentation of tuberculosis
|
|
670
|
|
|
‡a
Author's Influence of the surface coating on the cytotoxicity, genotoxicity and uptake of gold nanoparticles in human HepG2 cells.
|
|
670
|
|
|
‡a
Author's Inhibition of Glutathione Reductase by Isoproterenol Oxidation Products
|
|
670
|
|
|
‡a
Author's Inorganic mercury intoxication: A case report.
|
|
670
|
|
|
‡a
Author's Insights on the relationship between structure vs. toxicological activity of antibacterial rhodamine-labelled 3-hydroxy-4-pyridinone iron(III) chelators in HepG2 cells
|
|
670
|
|
|
‡a
Author's Involvement of reactive oxygen and nitrogen species on doxorubicin-induced toxicity to rat cortical neurons
|
|
670
|
|
|
‡a
Author's Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes
|
|
670
|
|
|
‡a
Author's Khat and synthetic cathinones: a review
|
|
670
|
|
|
‡a
Author's Kinetics of paraquat in the isolated rat lung: Influence of sodium depletion
|
|
670
|
|
|
‡a
Author's l-proline supplementation improves nitric oxide bioavailability and counteracts the blood pressure rise induced by angiotensin II in rats
|
|
670
|
|
|
‡a
Author's Leucoisoprenochrome-o-semiquinone formation in freshly isolated adult rat cardiomyocytes
|
|
670
|
|
|
‡a
Author's Lysine acetylsalicylate elicits full survival of Wistar rats exposed to a lethal dose of paraquat
|
|
670
|
|
|
‡a
Author's Lysine acetylsalicylate improves the safety of paraquat formulation in rats by increasing its elimination and preventing lung and kidney injury
|
|
670
|
|
|
‡a
Author's Lysine acetylsalicylate increases the safety of a paraquat formulation to freshwater primary producers: a case study with the microalga Chlorella vulgaris.
|
|
670
|
|
|
‡a
Author's MDMA impairs mitochondrial neuronal trafficking in a Tau- and Mitofusin2/Drp1-dependent manner.
|
|
670
|
|
|
‡a
Author's Mechanisms of P-gp inhibition and effects on membrane fluidity of a new rifampicin derivative, 1,8-dibenzoyl-rifampicin.
|
|
670
|
|
|
‡a
Author's Mercury fatal intoxication: Two case reports
|
|
670
|
|
|
‡a
Author's meta-Synephrine induces oxidative stress in freshly isolated cardiomyocytes
|
|
670
|
|
|
‡a
Author's Metabolic interactions between ethanol and MDMA in primary cultured rat hepatocytes.
|
|
670
|
|
|
‡a
Author's Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human
|
|
670
|
|
|
‡a
Author's Metabolic signature of methylone in primary mouse hepatocytes, at subtoxic concentrations
|
|
670
|
|
|
‡a
Author's Metabolism is required for the expression of ecstasy-induced cardiotoxicity in vitro
|
|
670
|
|
|
‡a
Author's Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in mice, after acute administration
|
|
670
|
|
|
‡a
Author's Metabolomic approaches in the discovery of potential urinary biomarkers of drug-induced liver injury
|
|
670
|
|
|
‡a
Author's Metabolomic approaches in the discovery of potential urinary biomarkers of drug-induced liver injury (DILI).
|
|
670
|
|
|
‡a
Author's Metabolomics analysis for biomarker discovery: advances and challenges.
|
|
670
|
|
|
‡a
Author's Methods for the analysis of transcriptome dynamics
|
|
670
|
|
|
‡a
Author's Methoxylated xanthones in the quality control of small centaury
|
|
670
|
|
|
‡a
Author's Methoxylated xanthones in the quality control of small centaury (Centaurium erythraea) flowering tops
|
|
670
|
|
|
‡a
Author's Methylone and MDPV activate autophagy in human dopaminergic SH-SY5Y cells: a new insight into the context of β-keto amphetamines-related neurotoxicity.
|
|
670
|
|
|
‡a
Author's Methylphenidate effects in the young brain: friend or foe?
|
|
670
|
|
|
‡a
Author's Mitochondria: key players in the neurotoxic effects of amphetamines.
|
|
670
|
|
|
‡a
Author's Mitochondrial Cumulative Damage Induced by Mitoxantrone: Late Onset Cardiac Energetic Impairment
|
|
670
|
|
|
‡a
Author's Mitochondrial impairment after mitoxantrone multi-administration to male Wistar rats
|
|
670
|
|
|
‡a
Author's Mitoxantrone: A comparative study of early and late toxic effects in rats
|
|
670
|
|
|
‡a
Author's Mitoxantrone is More Toxic than Doxorubicin in SH-SY5Y Human Cells: A 'Chemobrain' In Vitro Study.
|
|
670
|
|
|
‡a
Author's Mixture of “Ecstasy” and its metabolites are toxic to SH-SY5Y differentiated cells
|
|
670
|
|
|
‡a
Author's Modeling chronic brain exposure to amphetamines using primary rat neuronal cortical cultures.
|
|
670
|
|
|
‡a
Author's Modification of the conditions of the authorisation of BioPlus® 2B (Bacillus licheniformis DSM 5749 and Bacillus subtilis DSM 5750) for turkeys for fattening
|
|
670
|
|
|
‡a
Author's Modification of the terms of authorisation of lecithins as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Modification of the terms of authorisation regarding the maximum inclusion level of Maxiban® G160 (narasin and nicarbazin) for chickens for fattening
|
|
670
|
|
|
‡a
Author's Modification of the terms of the authorisation of Natuphos® E as a feed additive for chickens for fattening or reared for laying/breeding
|
|
670
|
|
|
‡a
Author's Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy.
|
|
670
|
|
|
‡a
Author's Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.
|
|
670
|
|
|
‡a
Author's Monoamine Oxidase-B Mediates Ecstasy-Induced Neurotoxic Effects to Adolescent Rat Brain Mitochondria
|
|
670
|
|
|
‡a
Author's Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy
|
|
670
|
|
|
‡a
Author's Neuronal nitric oxide synthase is a key factor in doxorubicin-induced toxicity to rat-isolated cortical neurons
|
|
670
|
|
|
‡a
Author's Neurotoxicity mechanisms of thioether ecstasy metabolites
|
|
670
|
|
|
‡a
Author's Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia
|
|
670
|
|
|
‡a
Author's Neurotoxicity of β-Keto Amphetamines: Deathly Mechanisms Elicited by Methylone and MDPV in Human Dopaminergic SH-SY5Y Cells.
|
|
670
|
|
|
‡a
Author's New findings on urinary prostate cancer metabolome through combined GC-MS and 1H NMR analytical platforms
|
|
670
|
|
|
‡a
Author's New formulation of paraquat with lysine acetylsalicylate with low mammalian toxicity and effective herbicidal activity
|
|
670
|
|
|
‡a
Author's New in silico insights into the inhibition of RNAP II by α-amanitin and the protective effect mediated by effective antidotes.
|
|
670
|
|
|
‡a
Author's NMR-based metabolomics studies of human prostate cancer tissue
|
|
670
|
|
|
‡a
Author's Non-targeted and targeted analysis of wild toxic and edible mushrooms using gas chromatography-ion trap mass spectrometry
|
|
670
|
|
|
‡a
Author's Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma.
|
|
670
|
|
|
‡a
Author's Optimisation and validation of a HS-SPME–GC–IT/MS method for analysis of carbonyl volatile compounds as biomarkers in human urine: Application in a pilot study to discriminate individuals with smoking habits
|
|
670
|
|
|
‡a
Author's Oxidation Process of Adrenaline in Freshly Isolated Rat Cardiomyocytes: Formation of Adrenochrome, Quinoproteins, and GSH Adduct
|
|
670
|
|
|
‡a
Author's P-glycoprotein activation by 1-(propan-2-ylamino)-4-propoxy-9H-thioxanthen-9-one (TX5) in rat distal ileum: ex vivo and in vivo studies
|
|
670
|
|
|
‡a
Author's P-glycoprotein activity in human Caucasian male lymphocytes does not follow its increased expression during aging
|
|
670
|
|
|
‡a
Author's P-glycoprotein expression and activity are differently modulated by Colchicine in Caco-2 cells: In vitro and in silico studies
|
|
670
|
|
|
‡a
Author's P-glycoprotein induction: an antidotal pathway for paraquat-induced lung toxicity
|
|
670
|
|
|
‡a
Author's P-glycoprotein induction as a cellular protection tool against xenobiotics toxicity
|
|
670
|
|
|
‡a
Author's P-glycoprotein induction in Caco-2 cells by newly synthetized thioxanthones prevents paraquat cytotoxicity.
|
|
670
|
|
|
‡a
Author's Paraquat: Molecular Mechanisms of Neurotoxicity and its Relation with Autophagy
|
|
670
|
|
|
‡a
Author's Paraquat research: do recent advances in limiting its toxicity make its use safer?
|
|
670
|
|
|
‡a
Author's Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases--a mechanistic approach
|
|
670
|
|
|
‡a
Author's Pharmacological concentrations of mitoxantrone are able to transiently activate caspases and dually modify glutathione pathways in HL-1 cells
|
|
670
|
|
|
‡a
Author's Piperazine compounds as drugs of abuse.
|
|
670
|
|
|
‡a
Author's Piperazine designer drugs are cytotoxic to human neuroblastoma SH-SY5Y cells
|
|
670
|
|
|
‡a
Author's Piperazine designer drugs induce toxicity in cardiomyoblast h9c2 cells through mitochondrial impairment.
|
|
670
|
|
|
‡a
Author's Piperazine designer drugs present cytotoxicity to primary rat hepatocytes
|
|
670
|
|
|
‡a
Author's Pixantrone, a new anticancer drug with the same old cardiac problems? An in vitro study with differentiated and non-differentiated H9c2 cells
|
|
670
|
|
|
‡a
Author's Postmortem analyses unveil the poor efficacy of decontamination, anti-inflammatory and immunosuppressive therapies in paraquat human intoxications
|
|
670
|
|
|
‡a
Author's Potential effects of non-conjugated metabolites of propofol in clinical variables
|
|
670
|
|
|
‡a
Author's Prevalence and influence of tuberculosis in the neurologic manifestations of the Human T cell lymphotropic virus type 1
|
|
670
|
|
|
‡a
Author's Prevalence and influence of tuberculosis in the neurologic manifestations of the Human T cell lymphotropic virus type 1 (HTLV-1).
|
|
670
|
|
|
‡a
Author's Pro-oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes
|
|
670
|
|
|
‡a
Author's Protective activity of Hypericum androsaemum infusion against tert-butyl hydroperoxide-induced oxidative damage in isolated rat hepatocytes
|
|
670
|
|
|
‡a
Author's Quantification of 1-(propan-2-ylamino)-4-propoxy-9H-thioxanthen-9-one (TX5), a newly synthetized P-glycoprotein inducer/activator, in biological samples: method development and validation.
|
|
670
|
|
|
‡a
Author's Quantification of Alpha -amanitin in biological samples by HPLC using simultaneous UV- diode array and electrochemical detection
|
|
670
|
|
|
‡a
Author's Quantification of doping compounds in faecal samples from racing pigeons, by liquid chromatography-tandem mass spectrometry
|
|
670
|
|
|
‡a
Author's Quantification of Methadone and Main Metabolites in Nails.
|
|
670
|
|
|
‡a
Author's Quantification of paraquat in postmortem samples by gas chromatography-ion trap mass spectrometry and review of the literature.
|
|
670
|
|
|
‡a
Author's Quantification of Total and Hexavalent Chromium in Lager Beers: Variability between Styles and Estimation of Daily Intake of Chromium from Beer
|
|
670
|
|
|
‡a
Author's Quantification of total chromium and hexavalent chromium in UHT milk by ETAAS
|
|
670
|
|
|
‡a
Author's Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
|
|
670
|
|
|
‡a
Author's RBE4 cells are highly resistant to paraquat-induced cytotoxicity: studies on uptake and efflux mechanisms.
|
|
670
|
|
|
‡a
Author's Reactivity of paraquat with sodium salicylate: formation of stable complexes.
|
|
670
|
|
|
‡a
Author's Renal cell carcinoma: a critical analysis of metabolomic biomarkers emerging from current model systems.
|
|
670
|
|
|
‡a
Author's Repeated Administration of d-Amphetamine Results in a Time-dependent and Dose-independent Sustained Increase in Urinary Excretion of p-Hydroxyamphetamine in Mice
|
|
670
|
|
|
‡a
Author's Role of metabolites in MDMA
|
|
670
|
|
|
‡a
Author's Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells
|
|
670
|
|
|
‡a
Author's Safety and efficacy of 26 compounds belonging to chemical group 3 (α,β-unsaturated straight-chain and branched-chain aliphatic primary alcohols, aldehydes, acids and esters) when used as flavourings for all animal species and categories
|
|
670
|
|
|
‡a
Author's Safety and efficacy of 3-phytase FLF1000 as a feed additive for chickens reared for laying and minor poultry species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of 3-phytase FLF1000 as a feed additive for pigs for fattening and minor porcine species for growing
|
|
670
|
|
|
‡a
Author's Safety and efficacy of 3-phytase FSF10000 as a feed additive for chickens for fattening or reared for laying, laying hens and minor poultry species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of 4-phenylbut-3-en-2-one and benzophenone belonging to chemical group 21 when used as flavouring compounds for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of 8-mercapto-p-menthan-3-one and p-menth-1-ene-8-thiol belonging to chemical group 20 when used as flavourings for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of a dried aqueous ethanol extract of leaves from Olea europaea L. when used as a sensory additive in feed for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of a dried aqueous ethanol extract of Melissa officinalis L. leaves when used as a sensory additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of a molybdenum compound (E7) sodium molybdate dihydrate as feed additive for sheep based on a dossier submitted by Trouw Nutrition International B.V.
|
|
670
|
|
|
‡a
Author's Safety and efficacy of a super critical carbon dioxide extract of Humulus lupulus L. flos when used as a feed flavouring for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of a tincture derived from Artemisia vulgaris L. (Mugwort tincture) when used as a sensory additive in feed for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of a tincture derived from Verbascum thapsus L. when used as a sensory additive in feed for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Actisaf® Sc47 (Saccharomyces cerevisiae CNCM I-4407) as a feed additive for cattle for fattening, dairy cows, weaned piglets and sows
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Alpha -amylase from Bacillus amyloliquefaciens DSM 9553, Bacillus amyloliquefaciens NCIMB 30251, Aspergillus oryzae CBS 585.94 and Aspergillus oryzae ATTC SD-5374, endo-1,4-beta-glucanase from Trichoderma reesei ATCC PTA-10001,
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Alterion NE®
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Alterion NE® (Bacillus subtilis DSM 29784) as a feed additive for chickens for fattening and chickens reared for laying
|
|
670
|
|
|
‡a
Author's Safety and efficacy of aluminosilicate of sodium, potassium, calcium and magnesium as a feed additive for pigs
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Amylofeed® (endo-1,3(4)-β-glucanase and endo-1,4-β-xylanase and α-amylase) as a feed additive for piglets and minor growing porcine species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Amylofeed® (endo‐1,3(4)‐β‐glucanase and endo‐1,4‐β‐xylanase and α‐amylase) as a feed additive for piglets and minor porcine species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of an essential oil from Elettaria cardamomum (L.) Maton when used as a sensory additive in feed for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of an essential oil from Origanum vulgare ssp. hirtum (Link) Ietsw. for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of an essential oil from Origanum vulgare subsp. hirtum
|
|
670
|
|
|
‡a
Author's Safety and efficacy of an essential oil from Origanum vulgare subsp. hirtum (Link) letsw. var. Vulkan when used as a sensory additive in feed for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of an essential oil of Origanum vulgare ssp. hirtum (Link) leetsw. for all poultry species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of APSA PHYTAFEED® 20,000 GR/L (6-phytase) as a feed additive for chickens for fattening, chickens reared for laying and minor growing poultry species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of APSA PHYTAFEED® 20,000 GR/L (6-phytase) as a feed additive for piglets (suckling and weaned) and growing minor porcine species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of APSA PHYTAFEED® 20,000 GR/L (6-phytase) as a feed additive for pigs for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of APSA PHYTAFEED® 20,000 GR/L (6-phytase) as a feed additive for turkeys for fattening, turkeys reared for breeding and minor poultry species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of aryl‐substituted primary alcohol, aldehyde, acid, ester and acetal derivatives belonging to chemical group 22 when used as flavourings for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of astaxanthin-dimethyldisuccinate (Carophyll® Stay-Pink 10%-CWS) for salmonids, crustaceans and other fish
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Availa®Cr (chromium chelate of DL-methionine) as a feed additive for dairy cows
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Avatec® 150G (lasalocid A sodium) as a feed additive for chickens for fattening and chickens reared for laying
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Avatec® 150G (lasalocid A sodium) for chickens for fattening and chickens reared for laying, and modification of the terms of authorisation for chickens for fattening, chickens reared for laying, turkeys for fattening, minor...
|
|
670
|
|
|
‡a
Author's Safety and efficacy of AviMatrix® (benzoic acid, calcium formate and fumaric acid) for chickens for fattening, chickens reared for laying, minor avian species for fattening and minor avian species reared to point of lay
|
|
670
|
|
|
‡a
Author's Safety and efficacy of AviPlus® as a feed additive for turkeys for fattening, turkeys reared for breeding and suckling piglets
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Avizyme® 1505 (endo-1,4-beta-xylanase, subtilisin and Alpha -amylase) for all poultry species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Axtra®XAP 104 TPT (endo-1,4-xylanase, protease and Alpha -amylase) as a feed additive for chickens for fattening, laying hens and minor poultry species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of B-Act® (Bacillus licheniformis DSM 28710) as a feed additive for turkeys for fattening, turkeys reared for breeding and minor poultry species for fattening or raised for laying
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Bacillus amyloliquefaciens
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Bacillus amyloliquefaciens (NCIMB 30229) as a silage additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Bacillus licheniformis DSM 32457 as a silage additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Bacillus subtilis DSM 28343 as a feed additive for calves for rearing
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Bacillus subtilis DSM 28343 for pigs for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Bacillus subtilis KCCM 10673P and Aspergillus oryzae KCTC 10258BP when used as a technological feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Bacillus subtilis PB6
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Bacillus subtilis PB6 (Bacillus subtilis ATCC PTA‐6737) as a feed additive for sows
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Bacillus subtilisPB6 (Bacillus velezensisATCC PTA-6737) as a feed additive for chickens for fattening, chickens reared for laying, minor poultry species (except for laying purposes), ornamental, sporting and game birds
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Belfeed B MP/ML (endo-1,4-β-xylanase) as a feed additive for sows, in order to have benefits in piglets, and for all porcine species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Beltherm MP/ML (endo-1,4-beta-xylanase) as a feed additive for chickens for fattening, chickens reared for laying, turkeys for fattening, turkeys reared for breeding, turkeys for breeding purposes and minor poultry species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Beltherm MP/ML (endo-1,4-beta-xylanase) as a feed additive for piglets, pigs for fattening and other porcine species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of bentonite as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of benzoic acid as a technological feed additive for weaned piglets and pigs for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of benzoic acid for pigs and poultry
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Bergazym® P100 (endo‐1,4‐β‐xylanase) as a feed additive for chickens for fattening, weaned piglets and pigs for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Bergazym® P100 (endo-1,4-β-xylanase) as a feed additive for other birds for fattening, ornamental birds and other growing Suidae
|
|
670
|
|
|
‡a
Author's Safety and efficacy of betaine anhydrous for food-producing animal species based on a dossier submitted by AB Vista
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Biacton® (Lactobacillus farciminis CNCM I-3740) as a feed additive for chickens for fattening, turkeys for fattening and laying hens
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Biomin®DC-C as a zootechnical feed additive for weaned piglets
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Biomin® DC-P as a zootechnical feed additive for chickens for fattening, chickens reared for laying and minor avian species to the point of lay
|
|
670
|
|
|
‡a
Author's Safety and efficacy of BioWorma® (Duddingtonia flagrans NCIMB 30336) as a feed additive for all grazing animals
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Bonvital (Enterococcus faecium, DSM 7134) as an additive in water for drinking for sows
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Bonvital® (Enterococcus faeciumDSM 7134) as a feed additive for laying hens
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Bonvital® (Enterococcus faeciumDSM 7134) as a feed additive for laying hens
|
|
670
|
|
|
‡a
Author's Safety and efficacy of butylated hydroxyanisole (BHA) as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Calsporin®
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Calsporin® (Bacillus subtilis DSM 15544) as a feed additive for dogs
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Calsporin® (Bacillus subtilis DSM 15544) as a feed additive for pigs for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Calsporin® (Bacillus subtilis DSM 15544) for all poultry species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Calsporin® (Bacillus subtilis DSM 15544) for sows and suckling piglets
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Capsozyme SB Plus (α-galactosidase and endo-1,4-β-xylanase) as a feed additive for poultry species for fattening or reared for laying and ornamental birds
|
|
670
|
|
|
‡a
Author's Safety and efficacy of CI-FER™ (ferric citrate chelate) as a zootechnical feed additive for suckling and weaned piglets and minor porcine species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Cinergy® Life B3 HiCon (Bacillus amyloliquefaciens NRRL B-50508, B. amyloliquefaciens NRRL B-50509 and Bacillus subtilis NRRL B-50510) as a feed additive for pigs for fattening and minor porcine species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of cis‐norbixin di‐potassium salt
|
|
670
|
|
|
‡a
Author's Safety and efficacy of cis‐norbixin di‐potassium salt (annatto F) for cats and dogs
|
|
670
|
|
|
‡a
Author's Safety and efficacy of concentrated liquid l-lysine (base) and l-lysine monohydrochloride produced by fermentation with Corynebacterium casei KCCM 80190 as feed additives for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of copper chelates of lysine and glutamic acid as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Correlinkâ„¢ ABS1781 Bacillus subtilis (Bacillus velezensisNRRL B-67259) as a feed additive for all growing poultry species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Correlinkâ„¢ ABS747 Bacillus subtilis (Bacillus velezensis NRRL B-67257) as a feed additive for all growing poultry species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Correlink™ ABS1781 Bacillus subtilis (Bacillus velezensisNRRL B-67259) as a feed additive for all growing poultry species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Correlink™ ABS747 Bacillus subtilis (Bacillus velezensis NRRL B-67257) as a feed additive for all growing poultry species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of COXAM® (amprolium hydrochloride) for chickens for fattening and chickens reared for laying
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Coxar® (nicarbazin) for turkeys for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Coxiril® (diclazuril) for chickens reared for laying
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Coxiril® (diclazuril) for pheasants
|
|
670
|
|
|
‡a
Author's Safety and efficacy of cumin tincture (Cuminum cyminum L.) when used as a sensory additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Deccox® (decoquinate) for chickens for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of 'dry grape extract 60-20' when used as feed flavouring for dogs
|
|
670
|
|
|
‡a
Author's Safety and efficacy of DSP® (Na2EDTA, tannin-rich extract of Castanea sativa, thyme oil and origanum oil) for pigs for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of EB15 10 (Bacillus subtilis DSM 25841) as a feed additive for piglets (suckling and weaned), pigs for fattening, sows in order to have benefits in piglets, sows for reproduction and minor porcine species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of EB15 10 (Bacillus subtilis DSM 25841) as a feed additive for weaned piglets and minor porcine species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of ECONASE® XT (endo-1,4-β-xylanase) as a feed additive for laying hens
|
|
670
|
|
|
‡a
Author's Safety and efficacy of ECONASE® XT (endo-1,4-β-xylanase) as a feed additive for pigs for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of eight compounds belonging to different chemical groups when used as flavourings for cats and dogs
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Elancoban® G200 (monensin sodium) for chickens for fattening, chickens reared for laying and turkeys
|
|
670
|
|
|
‡a
Author's Safety and efficacy of ENZY CARBOPLUS® (endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase) as a feed additive for avian species, weaned piglets and minor weaned porcine species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of essential oil, oleoresin and tincture from Zingiber officinale Roscoe when used as sensory additives in feed for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of ethyl cellulose for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of FRA® Octazyme C Dry (endo-1,4-β-xylanase, mannan-endo-1,4-β-mannosidase, α-amylase, endo-1,3(4)-β-glucanase, pectinase, endo-1,4-β-glucanase, protease, α-galactosidase) as a feed additive for weaned piglets and chickens for fa
|
|
670
|
|
|
‡a
Author's Safety and efficacy of FRA® Octazyme C Dry (α‐galactosidase, α‐amylase, endo‐1,3(4)‐β‐glucanase, endo‐1,4‐β‐glucanase, mannan‐endo‐1,4‐β‐mannosidase, pectinase, protease, endo‐1,4‐β‐xylanase) for chickens for fattening and weaned piglets
|
|
670
|
|
|
‡a
Author's Safety and efficacy of FSF10000 and FLF1000 (3-phytase) as a feed additive for turkeys for fattening or reared for breeding, pigs for fattening and minor porcine species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of fumonisin esterase from Komagataella phaffii DSM 32159 as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of fumonisin esterase from Komagataella phaffii DSM 32159 as a technological feed additive for pigs and poultry
|
|
670
|
|
|
‡a
Author's Safety and efficacy of GalliPro® Fit (Bacillus subtilis DSM 32324, Bacillus subtilis DSM 32325 and Bacillus amyloliquefaciens DSM 25840) for all poultry species for fattening or reared for laying/breeding
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Hemicell® HT (endo‐1,4‐β‐d‐mannanase) as a feed additive for chickens for fattening, chickens reared for laying, turkey for fattening, turkeys reared for breeding, weaned piglets, pigs for fattening and minor poultry and por...
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Hemicell® HT (endo-1,4-β-mannanase) as a feed additive for chickens for fattening, chickens reared for laying, turkey for fattening, turkeys reared for breeding, weaned piglets, pigs for fattening and minor poultry and porcine
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Hemicell®-L (endo-1,4-β-mannanase) as a feed additive for chickens for fattening or reared for laying, turkeys for fattening or reared for breeding and minor poultry species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of HOSTAZYM® X (endo-1,4-beta-xylanase) as a feed additive for rabbits for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of HOSTAZYM® X (endo‐1,4‐β‐xylanase) as a feed additive for carps
|
|
670
|
|
|
‡a
Author's Safety and efficacy of HOSTAZYM® X (endo‐1,4‐β‐xylanase) as a feed additive for chickens reared for laying and minor poultry species reared for laying
|
|
670
|
|
|
‡a
Author's Safety and efficacy of hydroxy analogue of methionine and its calcium salt (ADRY+®) for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of hydroxypropyl cellulose for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of hydroxypropyl methyl cellulose for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of iron chelates of lysine and glutamic acid as feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of iron dextran as a feed additive for piglets
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Kelforce® (l-glutamic acid, N,N-diacetic acid, tetrasodium salt (GLDA-Na4)) as a feed additive for chickens for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l‐arginine produced by Corynebacterium glutamicum KCCM 80099 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-arginine produced by fermentation using Corynebacterium glutamicum KCCM 10741P for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-arginine produced by fermentation with Corynebacterium glutamicum KCCM 80182 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-arginine produced by fermentation with Escherichia coli NITE BP-02186 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-cysteine hydrochloride monohydrate produced by fermentation using Escherichia coli KCCM 80180 and Escherichia coli KCCM 80181 as a flavouring additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-cysteine monohydrochloride monohydrate produced by fermentation using Escherichia coli KCCM 80109 and Escherichia coli KCCM 80197 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-cystine produced using Pantoea ananatis strain NITE BP-02525 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-glutamine produced using Corynebacterium glutamicum NITE BP-02524 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and Efficacy of l-histidine monohydrochloride monohydrate produced by fermentation using Escherichia coli KCCM 80212 as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-histidine monohydrochloride monohydrate produced by fermentation with Escherichia coli (NITE BP-02526) for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-histidine monohydrochloride monohydrate produced using Corynebacterium glutamicum KCCM 80172 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-histidine monohydrochloride monohydrate produced using Corynebacterium glutamicum KCCM 80179 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-isoleucine produced by fermentation with Corynebacterium glutamicum KCCM 80189 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-leucine produced by fermentation with Escherichia coli NITE BP-02351 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-lysine monohydrochloride and concentrated liquid l-lysine (base) produced by fermentation using Corynebacterium glutamicum strain KCCM 10227 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-lysine monohydrochloride and concentrated liquid l-lysine (base) produced by fermentation using Corynebacterium glutamicum strain NRRL B-50775 for all animal species based on a dossier submitted by ADM
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-lysine monohydrochloride and concentrated liquid l-lysine (base) produced by fermentation using Corynebacterium glutamicum strains NRRL-B-67439 or NRRL B-67535 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-lysine monohydrochloride and concentrated liquid l-lysine (base) produced by fermentation with <i>Corynebacterium glutamicum</i> KCCM 80216 as feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-lysine monohydrochloride and concentrated liquid l-lysine (base) produced by fermentation with <i>Corynebacterium glutamicum</i>KCTC 12307BP as feed additives for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-lysine monohydrochloride and l-lysine sulfate produced using Corynebacterium glutamicum CCTCC M 2015595 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-lysine monohydrochloride and l-lysine sulfate produced using Corynebacterium glutamicum CGMCC 7.266 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-lysine monohydrochloride produced by fermentation with Corynebacterium glutamicum DSM 32932 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-lysine sulfate produced by fermentation using Corynebacterium glutamicum KFCC 11043 as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-methionine produced by fermentation with Corynebacterium glutamicum KCCM 80184 and Escherichia coli KCCM 80096 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-threonine produced by fermentation with Corynebacterium glutamicum ■■■■■ for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l‐threonine produced by fermentation with Escherichia coli CGMCC 11473 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-threonine produced using <i>Escherichia coli</i>CGMCC 13325 as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-tryptophan produced by fermentation using Escherichia coli CGMCC 7.267 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-tryptophan produced by fermentation with Corynebacterium glutamicum KCCM 80176 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-tryptophan produced by fermentation with Escherichia coli CGMCC 7.248 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-tryptophan produced by fermentation with Escherichia coli KCCM 10534 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-tryptophan produced by fermentation with Escherichia coli KCCM 80135 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-tryptophan produced by fermentation with Escherichia coli KCCM 80152 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-tryptophan produced with Escherichia coli CGMCC 11674 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-valine produced by fermentation using Corynebacterium glutamicum KCCM 11201P for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-valine produced by fermentation using Corynebacterium glutamicumCGMCC 7.358 as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-valine produced by fermentation using Escherichia coli KCCM 80159 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of l-valine produced using Corynebacterium glutamicum CGMCC 11675 for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Lactobacillus acidophilus D2/CSL
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Lactobacillus acidophilus D2/CSL (Lactobacillus acidophilus CECT 4529) as a feed additive for cats and dogs
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Lactobacillus acidophilus D2/CSL (Lactobacillus acidophilus CECT 4529) as a feed additive for chickens for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Lactobacillus buchneri DSM 29026 as a silage additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Lactobacillus buchneri NRRL B‐50733 as a silage additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Lactobacillus casei DSM 28872 as a silage additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Lactobacillus hilgardii CNCM I‐4785 as a silage additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Lactobacillus parafarraginis DSM 32962 as a silage additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Lactobacillus plantarum DSM 29024 as a silage additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Lactobacillus reuteri NBF-1 (DSM 32203) as a feed additive for dogs
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Lactobacillus reuteri NBF-2 (DSM 32264) as a feed additive for cats
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Lactobacillus rhamnosus CNCM I-3698 and Lactobacillus farciminis CNCM I-3699 as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Lactobacillus rhamnosus DSM 29226 as a silage additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Levucell® SB
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Levucell®SB (Saccharomyces cerevisiae CNCM I-1079) as a feed additive for all pigs
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Levucell® SB (Saccharomyces cerevisiae CNCM I‐1079) as a feed additive for chickens for fattening and minor poultry species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Levucell®SB (Saccharomyces cerevisiae CNCM I-1079) as a feed additive for turkeys for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Levucell SC® (Saccharomyces cerevisiae CNCM I-1077) as a feed additive for calves and minor ruminant species and camelids at the same developmental stage
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Levucell® SC (Saccharomyces cerevisiae CNCM I‐1077) as a feed additive for dairy cows, cattle for fattening, minor ruminant species and camelids
|
|
670
|
|
|
‡a
Author's Safety and efficacy of lutein and lutein/zeaxanthin extracts from Tagetes erecta for poultry for fattening and laying (except turkeys)
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Manganese chelates of lysine and glutamic acid as feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of methyl cellulose for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of microcrystalline cellulose for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of microorganism DSM 11798 as a technological additive for all avian species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Monimax® (monensin sodium and nicarbazin) for chickens for fattening and chickens reared for laying
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Monimax® (monensin sodium and nicarbazin) for turkeys for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of monosodium l-glutamate monohydrate produced by Corynebacterium glutamicum KCCM 80188 as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Monteban® G100 (narasin) for chickens for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Monteban® G100 (narasin) for ducks for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of muramidase from Trichoderma reesei DSM 32338 as a feed additive for chickens for fattening and minor poultry species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of muramidase from Trichoderma reesei DSM 32338 as a feed additive for turkeys for fattening, turkeys reared for breeding, chickens reared for breeding and other poultry species reared for breeding
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Natugrain®TS/TS L (endo-1,4-beta-xylanase and endo-1,4-beta-glucanase) as a feed additive for sows
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Natuphos® E
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Natuphos® E (6‐phytase) as a feed additive for avian and porcine species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Natuphos® E (6-phytase) as a feed additive for laying hens, minor poultry and other avian species for laying
|
|
670
|
|
|
‡a
Author's Safety and efficacy of natural mixture of illite, montmorillonite and kaolinite for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of natural mixtures of talc (steatite) and chlorite (E 560) as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Nimicoat® (carvacrol) as a zootechnical additive for weaned piglets
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Nutrase P (6-phytase) for chickens for fattening, other poultry for fattening, reared for laying and ornamental birds
|
|
670
|
|
|
‡a
Author's Safety and efficacy of oct-1-en-3-ol, pent-1-en-3-ol, oct-1-en-3-one, oct-1-en-3-yl acetate, isopulegol and 5-methylhept-2-en-4-one, belonging to chemical group 5 and of isopulegone and α-damascone belonging to chemical group 8 when used as flavouri
|
|
670
|
|
|
‡a
Author's Safety and efficacy of OPTIPHOS®
|
|
670
|
|
|
‡a
Author's Safety and efficacy of OPTIPHOS® (6‐phytase) as a feed additive for finfish
|
|
670
|
|
|
‡a
Author's Safety and efficacy of OptiPhos®PLUS (6 phytase) for laying hens, turkeys for breeding, chickens for breeding, minor poultry species for egg production purposes and breeding
|
|
670
|
|
|
‡a
Author's Safety and efficacy of OptiPhos® PLUS for poultry species for fattening, minor poultry species reared for breeding and ornamental birds
|
|
670
|
|
|
‡a
Author's Safety and efficacy of OptiPhos®PLUS for suckling and weaned piglets, pigs for fattening, sows, other minor pig species for fattening and other minor reproductive pig species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Panavital feed (d-glyceric acid) for chickens for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Pediococcus parvulus DSM 28875 as a silage additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Pediococcus pentosaceus DSM 32291 as a silage additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of ponceau 4R for cats, dogs and ornamental fish
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Probion Forte®
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Probion Forte® (Bacillus subtilis KCCM 10941P and Bacillus coagulans KCCM 11093P) as a feed additive for chickens for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Probion forte® (Bacillus subtilis KCCM 10941P and Bacillus coagulans KCCM 11093P) for chickens for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Probiotic Lactina® (Enterococcus faecium NBIMCC 8270, Lactobacillus acidophilus NBIMCC 8242, Lactobacillus helveticus NBIMCC 8269, Lactobacillus delbrueckii ssp. lactis NBIMCC 8250, Lactobacillus delbrueckii ssp. bulgaricus NB
|
|
670
|
|
|
‡a
Author's Safety and efficacy of propyl gallate for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of pyrazine derivatives including saturated ones belonging to chemical group 24 when used as flavourings for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Robenz® 66G (robenidine hydrochloride) for chickens for fattening and turkeys for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of RONOZYME®WX CT/L (endo-1,4-β-xylanase) as a feed additive for sows for reproduction
|
|
670
|
|
|
‡a
Author's Safety and efficacy of RONOZYME® WX (endo‐1,4‐β‐xylanase) as a feed additive for laying hens
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Sacox® microGranulate
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Sacox® microGranulate (salinomycin sodium) for chickens for fattening and chickens reared for laying
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Sacox® microGranulate (salinomycin sodium) for rabbits for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of saponified paprika extract, containing capsanthin as main carotenoid source, for poultry for fattening and laying (except turkeys)
|
|
670
|
|
|
‡a
Author's Safety and efficacy of selenium‐enriched yeast
|
|
670
|
|
|
‡a
Author's Safety and efficacy of selenium‐enriched yeast (Saccharomyces cerevisiae CNCM I‐3399) for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of sodium and potassium alginate for pets, other non food‐producing animals and fish
|
|
670
|
|
|
‡a
Author's Safety and efficacy of sodium carboxymethyl cellulose for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of sodium saccharin when used as a feed flavour for piglets, pigs for fattening, calves for rearing and calves for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of sodium selenate as feed additive for ruminants
|
|
670
|
|
|
‡a
Author's Safety and efficacy of sorbitan monolaurate as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of STABILFLOR® as a zootechnical feed additive for pigs for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of STENOROL® (halofuginone hydrobromide) as a feed additive for chickens for fattening and turkeys
|
|
670
|
|
|
‡a
Author's Safety and efficacy of STENOROL® (halofuginone hydrobromide) as a feed additive for chickens for fattening and turkeys
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Taminizer D (dimethylglycine sodium salt) as a feed additive for chickens for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of TechnoSpore® (Bacillus coagulans DSM 32016) for piglets, other growing Suidae, chickens for fattening, other poultry for fattening and ornamental birds
|
|
670
|
|
|
‡a
Author's Safety and efficacy of turmeric extract, turmeric oil, turmeric oleoresin and turmeric tincture from Curcuma longa L. rhizome when used as sensory additives in feed for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of TYFER™ (ferric tyrosine chelate) as a zootechnical feed additive for chickens, turkeys and minor poultry species for fattening or reared for laying/breeding
|
|
670
|
|
|
‡a
Author's Safety and efficacy of vermiculite as a feed additive for pigs, poultry, bovines, sheep, goats, rabbits and horses
|
|
670
|
|
|
‡a
Author's Safety and efficacy of VevoVitall®
|
|
670
|
|
|
‡a
Author's Safety and efficacy of VevoVitall® (benzoic acid) as feed additive for minor porcine species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of VevoVitall® (benzoic acid) as feed additive for pigs for fattening
|
|
670
|
|
|
‡a
Author's Safety and efficacy of vitamin B12 (in the form of cyanocobalamin) produced by Ensifer spp. as a feed additive for all animal species based on a dossier submitted by VITAC EEIG
|
|
670
|
|
|
‡a
Author's Safety and efficacy of vitamin B2 (riboflavin 5'-phosphate ester monosodium salt) for all animal species when used in water for drinking
|
|
670
|
|
|
‡a
Author's Safety and efficacy of vitamin B2 (riboflavin) produced by Ashbya gossypii ■■■■■ for all animal species based on a dossier submitted by BASF SE
|
|
670
|
|
|
‡a
Author's Safety and efficacy of zinc chelate of methionine sulfate for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of zinc chelates of lysine and glutamic acid as feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of Zinc-l-Selenomethionine as feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of ZM16 10 (Bacillus amyloliquefaciens DSM 25840) as a feed additive for sows in order to have benefits in piglets, sows for reproduction, piglets (suckling and weaned), pigs for fattening and minor porcine species
|
|
670
|
|
|
‡a
Author's Safety and efficacy of ZM16 10 (Bacillus amyloliquefaciens DSM 25840) as a feed additive for weaned piglets and minor porcine species
|
|
670
|
|
|
‡a
Author's Safety and nutritional value of a dried killed bacterial biomass from Escherichia coli (FERM BP‐10941) (PL73 (LM)) as a feed material for pigs, ruminants and salmonids
|
|
670
|
|
|
‡a
Author's Safety and nutritional value of a dried killed bacterial biomass from Escherichia coli (FERM BP‐10942) (PT73 (TM)) as a feed material for pigs, ruminants and salmonids
|
|
670
|
|
|
‡a
Author's Safety for the environment of Monimax® (monensin sodium and nicarbazin) for chickens for fattening, chickens reared for laying and for turkeys for fattening
|
|
670
|
|
|
‡a
Author's Safety for the environment of sorbitan monolaurate as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety for the environment of vitamin D3 for salmonids
|
|
670
|
|
|
‡a
Author's Safety of 3-phytase FLF1000 and FSF10000 as a feed additive for pigs for fattening and minor growing porcine species
|
|
670
|
|
|
‡a
Author's Safety of 31 flavouring compounds belonging to different chemical groups when used as feed additives for all animal species
|
|
670
|
|
|
‡a
Author's Safety of a tincture derived from Artemisia vulgaris L. (Mugwort tincture) when used as a sensory additive in feed for all animal species
|
|
670
|
|
|
‡a
Author's Safety of ammonium formate (E 295) for all animal species
|
|
670
|
|
|
‡a
Author's Safety of an essential oil from Origanum vulgare subsp. hirtum (Link) letsw. var. Vulkan when used as a sensory additive in feed for all animal species
|
|
670
|
|
|
‡a
Author's Safety of butylated hydroxy anisole (BHA) for all animal species
|
|
670
|
|
|
‡a
Author's Safety of cassia gum as a feed additive for cats and dogs based on a dossier submitted by Glycomer GmbH
|
|
670
|
|
|
‡a
Author's Safety of cassia gum as a feed additive for dogs and cats based on a dossier submitted by Glycomer GmbH
|
|
670
|
|
|
‡a
Author's Safety of cassia gum as a feed additive for dogs and cats based on a dossier submitted by Intercolloid
|
|
670
|
|
|
‡a
Author's Safety of cassia gum as a feed additive for dogs and cats based on a dossier submitted by Intercolloid (UK) Ltd
|
|
670
|
|
|
‡a
Author's Safety of concentrated l‐lysine (base), l‐lysine monohydrochloride and l‐lysine sulfate produced using different strains of Corynebacterium glutamicum for all animal species based on a dossier submitted by FEFANA asbl
|
|
670
|
|
|
‡a
Author's Safety of Endofeed® DC (endo‐1,3(4)‐β‐glucanase and endo‐1,4‐β‐xylanase) as a feed additive for chickens for fattening, laying hens, pigs for fattening and minor poultry and porcine species
|
|
670
|
|
|
‡a
Author's Safety of erythrosine for ornamental fish
|
|
670
|
|
|
‡a
Author's Safety of ethyl ester of β-apo-8'-carotenoic acid as a feed additive for poultry for fattening and poultry for laying
|
|
670
|
|
|
‡a
Author's Safety of hexamethylene tetramine for pigs, poultry, bovines, sheep, goats, rabbits and horses
|
|
670
|
|
|
‡a
Author's Safety of l‐lysine sulfate produced by fermentation with Escherichia coli CGMCC 3705 for all animal species
|
|
670
|
|
|
‡a
Author's Safety of l-threonine produced by fermentation with Escherichia coli CGMCC 11473 as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety of l-tryptophan produced using Escherichia coli CGMCC 11674 for all animal species
|
|
670
|
|
|
‡a
Author's Safety of l‐tryptophan technically pure, produced by Escherichia coli CGMCC 3667, for all animal species based on a dossier submitted by GBT Europe GmbH
|
|
670
|
|
|
‡a
Author's Safety of l‐tryptophan technically pure, produced by fermentation with Escherichia coli DSM 25084, KCCM 11132P and SARI12091203 for all animal species based on a dossier submitted by FEFANA Asbl
|
|
670
|
|
|
‡a
Author's Safety of lactic acid and calcium lactate when used as technological additives for all animal species
|
|
670
|
|
|
‡a
Author's Safety of Lactococcus lactis NCIMB 30160 as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety of Lancer® (lanthanide citrate) as a zootechnical additive for weaned piglets
|
|
670
|
|
|
‡a
Author's Safety of lignosulphonate for all animal species
|
|
670
|
|
|
‡a
Author's Safety of methanethiol [12.003] when used as a feed additive for all animal species
|
|
670
|
|
|
‡a
Author's Safety of natural mixture of dolomite plus magnesite and magnesium‐phyllosilicates
|
|
670
|
|
|
‡a
Author's Safety of natural mixture of dolomite plus magnesite and magnesium-phyllosilicates (Fluidol) for all animal species
|
|
670
|
|
|
‡a
Author's Safety of natural mixture of illite, montmorillonite and kaolinite (Argile Verte du Velay) for all animal species
|
|
670
|
|
|
‡a
Author's Safety of potassium diformate (Formi™ LHS) as a feed additive for sows, from ADDCON EUROPE GmbH
|
|
670
|
|
|
‡a
Author's Safety of vitamin B<sub>12</sub> (in the form of cyanocobalamin) produced by <i>Ensifer adhaerens</i>CNCM-I 5541 for all animal species
|
|
670
|
|
|
‡a
Author's Safety of vitamin B2 (80%) as riboflavin produced by Bacillus subtilis KCCM-10445 for all animal species
|
|
670
|
|
|
‡a
Author's Safety of vitamin D3 addition to feedingstuffs for fish
|
|
670
|
|
|
‡a
Author's Safety of zinc chelate of methionine sulfate for the target species
|
|
670
|
|
|
‡a
Author's Scientific Opinion on the safety and efficacy of Aviax 5% (semduramicin sodium) for chickens for fattening
|
|
670
|
|
|
‡a
Author's Selective determination of chromium
|
|
670
|
|
|
‡a
Author's Selective determination of chromium (VI) in powdered milk infant formulas by electrothermal atomization atomic absorption spectrometry after ion exchange
|
|
670
|
|
|
‡a
Author's Several transport systems contribute to the intestinal uptake of Paraquat, modulating its cytotoxic effects.
|
|
670
|
|
|
‡a
Author's Short- and long-term distribution and toxicity of gold nanoparticles in the rat after a single-dose intravenous administration
|
|
670
|
|
|
‡a
Author's Signs and Related Mechanisms of Ethanol Hepatotoxicity.
|
|
670
|
|
|
‡a
Author's Simultaneous determination of amphetamine derivatives in human urine after SPE extraction and HPLC-UV analysis.
|
|
670
|
|
|
‡a
Author's Single high dose dexamethasone treatment decreases the pathological score and increases the survival rate of paraquat-intoxicated rats
|
|
670
|
|
|
‡a
Author's ‘Smart’ but not safe: The potential hepatotoxicity of synthetic cathinones
|
|
670
|
|
|
‡a
Author's Snake venoms from Angola: Intra-specific variations and immunogenicity
|
|
670
|
|
|
‡a
Author's Statement on the safety and efficacy of lignosulphonate of magnesium (Caimabond) for all animal species
|
|
670
|
|
|
‡a
Author's Statement on the safety and efficacy of phosphoric acid 60% on silica carrier (UD60) for all animal species
|
|
670
|
|
|
‡a
Author's Statement on the safety and efficacy of Shellac for all animal species
|
|
670
|
|
|
‡a
Author's Strenuous exercise aggravates MDMA-induced skeletal muscle damage in mice.
|
|
670
|
|
|
‡a
Author's Structural isomerization of synephrine influences its uptake and ensuing glutathione depletion in rat-isolated cardiomyocytes
|
|
670
|
|
|
‡a
Author's Structure-cytotoxicity relationship profile of 13 synthetic cathinones in differentiated human SH-SY5Y neuronal cells
|
|
670
|
|
|
‡a
Author's Studies towards the synthesis of dicarboxylic acid metabolite of mitoxantrone: PS177
|
|
670
|
|
|
‡a
Author's Study of the intestinal uptake and permeability of gold nanoparticles using both in vitro and in vivo approaches
|
|
670
|
|
|
‡a
Author's Synephrine: from trace concentrations to massive consumption in weight-loss
|
|
670
|
|
|
‡a
Author's Synergistic toxicity of ethanol and MDMA towards primary cultured rat hepatocytes
|
|
670
|
|
|
‡a
Author's Synthesis and analysis of aminochromes by HPLC-photodiode array. Adrenochrome evaluation in rat blood.
|
|
670
|
|
|
‡a
Author's Synthesis and Cyclic Voltammetry Studies of 3,4-Methylenedioxymethamphetamine (MDMA) Human Metabolites
|
|
670
|
|
|
‡a
Author's The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury
|
|
670
|
|
|
‡a
Author's The hallucinogenic world of tryptamines: an updated review
|
|
670
|
|
|
‡a
Author's The heart as a target for xenobiotic toxicity: the cardiac susceptibility to oxidative stress
|
|
670
|
|
|
‡a
Author's The Main Metabolites of Fluorouracil + Adriamycin + Cyclophosphamide
|
|
670
|
|
|
‡a
Author's The Main Metabolites of Fluorouracil + Adriamycin + Cyclophosphamide (FAC) Are Not Major Contributors to FAC Toxicity in H9c2 Cardiac Differentiated Cells
|
|
670
|
|
|
‡a
Author's The metabolic profile of mitoxantrone and its relation with mitoxantrone-induced cardiotoxicity
|
|
670
|
|
|
‡a
Author's The mixture of "ecstasy" and its metabolites impairs mitochondrial fusion/fission equilibrium and trafficking in hippocampal neurons, at in vivo relevant concentrations.
|
|
670
|
|
|
‡a
Author's The mixture of "ecstasy" and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations
|
|
670
|
|
|
‡a
Author's The neurotoxicity of amphetamines during the adolescent period
|
|
670
|
|
|
‡a
Author's The neurotoxicity of hallucinogenic amphetamines in primary cultures of hippocampal neurons
|
|
670
|
|
|
‡a
Author's The new psychoactive substance 3-methylmethcathinone (3-MMC or metaphedrone) induces oxidative stress, apoptosis, and autophagy in primary rat hepatocytes at human-relevant concentrations
|
|
670
|
|
|
‡a
Author's The novel psychoactive substance 3-methylmethcathinone (3-MMC or metaphedrone): A review
|
|
670
|
|
|
‡a
Author's The Role of the Metabolism of Anticancer Drugs in Their Induced-Cardiotoxicity
|
|
670
|
|
|
‡a
Author's The study of oxidative stress in freshly isolated Ca(2+)-tolerant cardiomyocytes from the adult rat.
|
|
670
|
|
|
‡a
Author's The toxicity of N-methyl- Alpha -methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine
|
|
670
|
|
|
‡a
Author's Therapeutic concentrations of mitoxantrone elicit energetic imbalance in H9c2 cells as an earlier event
|
|
670
|
|
|
‡a
Author's Time dependent activation of transcription factors in freshly isolated cardiomyocytes: Adrenaline and reactive oxygen species incubation
|
|
670
|
|
|
‡a
Author's Tolerance and Bioaccumulation of Copper by the Entomopathogen Beauveria bassiana
|
|
670
|
|
|
‡a
Author's Tolerance and Bioaccumulation of Copper by the Entomopathogen Beauveria bassiana (Bals.-Criv.) Vuill. Exposed to Various Copper-Based Fungicides
|
|
670
|
|
|
‡a
Author's Tolerance and stress response of Macrolepiota procera to nickel
|
|
670
|
|
|
‡a
Author's Toxicity of amphetamines: an update
|
|
670
|
|
|
‡a
Author's Toxicity of the amphetamine metabolites 4-hydroxyamphetamine and 4-hydroxynorephedrine in human dopaminergic differentiated SH-SY5Y cells.
|
|
670
|
|
|
‡a
Author's Toxicological evaluation of lactose and chitosan delivered by inhalation
|
|
670
|
|
|
‡a
Author's Transference of total chromium and hexavalent chromium from soils to mushrooms
|
|
670
|
|
|
‡a
Author's Update on 1-benzylpiperazine (BZP) party pills.
|
|
670
|
|
|
‡a
Author's Validation of a HPLC-ECD method for the detection of adrenaline-GSH adducts in biological samples
|
|
670
|
|
|
‡a
Author's Validation of a HPLC-ECD method for the quantification of the highly reactive metabolite of ecstasy, N-methyl-α-methyldopamine, in human serum
|
|
670
|
|
|
‡a
Author's Validation of a Method To Quantify Copper and Other Metals in Olive Fruit by ETAAS. Application to the Residual Metal Control after Olive Tree Treatments with Different Copper Formulations
|
|
670
|
|
|
‡a
Author's Validation of an Electrothermal Atomization Atomic Absorption Spectrometry Method for Quantification of Total Chromium and Chromium
|
|
670
|
|
|
‡a
Author's Validation of an Electrothermal Atomization Atomic Absorption Spectrometry Method for Quantification of Total Chromium and Chromium(VI) in Wild Mushrooms and Underlying Soils
|
|
670
|
|
|
‡a
Author's Variability in phenolic composition of Hypericum androsaemum
|
|
670
|
|
|
‡a
Author's Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography–mass spectrometry
|
|
670
|
|
|
‡a
Author's Volatile profile of cork as a tool for classification of natural cork stoppers
|
|
670
|
|
|
‡a
Author's Volatilomics Reveals Potential Biomarkers for Identification of Renal Cell Carcinoma: An In Vitro Approach
|
|
670
|
|
|
‡a
Author's Water extracts of Brassica oleracea var. costata potentiate paraquat toxicity to rat hepatocytes in vitro.
|
|
670
|
|
|
‡a
Author's Καρκίνωμα νεφρικών κυττάρων: μια κριτική ανάλυση μεταβολικών βιοδεικτών που προκύπτουν από τα τρέχοντα μοντέλα συστημάτων.
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/ISNI|0000000068203673
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/99636870
|
|
909
|
|
|
‡a
(scopus) 25822248900
‡9
1
|
|
909
|
|
|
‡a
(orcid) 000000019895503x
‡9
1
|
|
919
|
|
|
‡a
studyofoxidativestressinfreshlyisolatedca2+tolerantcardiomyocytesfromtheadultrat
‡A
The study of oxidative stress in freshly isolated Ca(2+)-tolerant cardiomyocytes from the adult rat.
‡9
1
|
|
919
|
|
|
‡a
roleofthemetabolismofanticancerdrugsintheirinducedcardiotoxicity
‡A
The Role of the Metabolism of Anticancer Drugs in Their Induced-Cardiotoxicity
‡9
1
|
|
919
|
|
|
‡a
novelpsychoactivesubstance3methylmethcathinone32100ormetaphedroneareview
‡A
The novel psychoactive substance 3-methylmethcathinone (3-MMC or metaphedrone): A review
‡9
1
|
|
919
|
|
|
‡a
newpsychoactivesubstance3methylmethcathinone32100ormetaphedroneinducesoxidativestressapoptosisandautophagyinprimaryrathepatocytesathumanrelevantconcentrations
‡A
The new psychoactive substance 3-methylmethcathinone (3-MMC or metaphedrone) induces oxidative stress, apoptosis, and autophagy in primary rat hepatocytes at human-relevant concentrations
‡9
1
|
|
919
|
|
|
‡a
neurotoxicityofhallucinogenicamphetaminesinprimaryculturesofhippocampalneurons
‡A
The neurotoxicity of hallucinogenic amphetamines in primary cultures of hippocampal neurons
‡9
1
|
|
919
|
|
|
‡a
neurotoxicityofamphetaminesduringtheadolescentperiod
‡A
The neurotoxicity of amphetamines during the adolescent period
‡9
1
|
|
919
|
|
|
‡a
mixtureofecstasyanditsmetabolitesistoxictohumanshsy5ydifferentiatedcellsatinvivorelevantconcentrations
‡A
The mixture of "ecstasy" and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations
‡9
1
|
|
919
|
|
|
‡a
mixtureofecstasyanditsmetabolitesimpairsmitochondrialfusionfissionequilibriumandtraffickinginhippocampalneuronsatinvivorelevantconcentrations
‡A
The mixture of "ecstasy" and its metabolites impairs mitochondrial fusion/fission equilibrium and trafficking in hippocampal neurons, at in vivo relevant concentrations.
‡9
1
|
|
919
|
|
|
‡a
metabolicprofileofmitoxantroneanditsrelationwithmitoxantroneinducedcardiotoxicity
‡A
The metabolic profile of mitoxantrone and its relation with mitoxantrone-induced cardiotoxicity
‡9
1
|
|
919
|
|
|
‡a
mainmetabolitesoffluorouracil+adriamycin+cyclophosphamidefacarenotmajorcontributorstofactoxicityinh9c2cardiacdifferentiatedcells
‡A
The Main Metabolites of Fluorouracil + Adriamycin + Cyclophosphamide (FAC) Are Not Major Contributors to FAC Toxicity in H9c2 Cardiac Differentiated Cells
‡9
1
|
|
919
|
|
|
‡a
mainmetabolitesoffluorouracil+adriamycin+cyclophosphamide
‡A
The Main Metabolites of Fluorouracil + Adriamycin + Cyclophosphamide
‡9
1
|
|
919
|
|
|
‡a
heartasatargetforxenobiotictoxicitythecardiacsusceptibilitytooxidativestress
‡A
The heart as a target for xenobiotic toxicity: the cardiac susceptibility to oxidative stress
‡9
1
|
|
919
|
|
|
‡a
hallucinogenicworldoftryptaminesanupdatedreview
‡A
The hallucinogenic world of tryptamines: an updated review
‡9
1
|
|
919
|
|
|
‡a
agefactorformitoxantronescardiotoxicitymultipledosesrendertheadultmouseheartmoresusceptibletoinjury
‡A
The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury
‡9
1
|
|
919
|
|
|
‡a
synthesisandcyclicvoltammetrystudiesof34methylenedioxymethamphetaminemdmahumanmetabolites
‡A
Synthesis and Cyclic Voltammetry Studies of 3,4-Methylenedioxymethamphetamine (MDMA) Human Metabolites
‡9
1
|
|
919
|
|
|
‡a
synthesisandanalysisofaminochromesbyhplcphotodiodearrayadrenochromeevaluationinratblood
‡A
Synthesis and analysis of aminochromes by HPLC-photodiode array. Adrenochrome evaluation in rat blood.
‡9
1
|
|
919
|
|
|
‡a
synergistictoxicityofethanolandmdmatowardsprimaryculturedrathepatocytes
‡A
Synergistic toxicity of ethanol and MDMA towards primary cultured rat hepatocytes
‡9
1
|
|
919
|
|
|
‡a
synephrinefromtraceconcentrationstomassiveconsumptioninweightloss
‡A
Synephrine: from trace concentrations to massive consumption in weight-loss
‡9
1
|
|
919
|
|
|
‡a
studyoftheintestinaluptakeandpermeabilityofgoldnanoparticlesusingbothinvitroandinvivoapproaches
‡A
Study of the intestinal uptake and permeability of gold nanoparticles using both in vitro and in vivo approaches
‡9
1
|
|
919
|
|
|
‡a
studiestowardsthesynthesisofdicarboxylicacidmetaboliteofmitoxantroneps177
‡A
Studies towards the synthesis of dicarboxylic acid metabolite of mitoxantrone: PS177
‡9
1
|
|
919
|
|
|
‡a
structurecytotoxicityrelationshipprofileof13syntheticcathinonesindifferentiatedhumanshsy5yneuronalcells
‡A
Structure-cytotoxicity relationship profile of 13 synthetic cathinones in differentiated human SH-SY5Y neuronal cells
‡9
1
|
|
919
|
|
|
‡a
structuralisomerizationofsynephrineinfluencesitsuptakeandensuingglutathionedepletioninratisolatedcardiomyocytes
‡A
Structural isomerization of synephrine influences its uptake and ensuing glutathione depletion in rat-isolated cardiomyocytes
‡9
1
|
|
919
|
|
|
‡a
strenuousexerciseaggravatesmdmainducedskeletalmuscledamageinmice
‡A
Strenuous exercise aggravates MDMA-induced skeletal muscle damage in mice.
‡9
1
|
|
919
|
|
|
‡a
statementonthesafetyandefficacyofshellacforallanimalspecies
‡A
Statement on the safety and efficacy of Shellac for all animal species
‡9
1
|
|
919
|
|
|
‡a
statementonthesafetyandefficacyofphosphoricacid60onsilicacarrierud60forallanimalspecies
‡A
Statement on the safety and efficacy of phosphoric acid 60% on silica carrier (UD60) for all animal species
‡9
1
|
|
919
|
|
|
‡a
statementonthesafetyandefficacyoflignosulphonateofmagnesiumcaimabondforallanimalspecies
‡A
Statement on the safety and efficacy of lignosulphonate of magnesium (Caimabond) for all animal species
‡9
1
|
|
919
|
|
|
‡a
snakevenomsfromangolaintraspecificvariationsandimmunogenicity
‡A
Snake venoms from Angola: Intra-specific variations and immunogenicity
‡9
1
|
|
919
|
|
|
‡a
smartbutnotsafethepotentialhepatotoxicityofsyntheticcathinones
‡A
‘Smart’ but not safe: The potential hepatotoxicity of synthetic cathinones
‡9
1
|
|
919
|
|
|
‡a
singlehighdosedexamethasonetreatmentdecreasesthepathologicalscoreandincreasesthesurvivalrateofparaquatintoxicatedrats
‡A
Single high dose dexamethasone treatment decreases the pathological score and increases the survival rate of paraquat-intoxicated rats
‡9
1
|
|
919
|
|
|
‡a
simultaneousdeterminationofamphetaminederivativesinhumanurineafterspeextractionandhplcuvanalysis
‡A
Simultaneous determination of amphetamine derivatives in human urine after SPE extraction and HPLC-UV analysis.
‡9
1
|
|
919
|
|
|
‡a
signsandrelatedmechanismsofethanolhepatotoxicity
‡A
Signs and Related Mechanisms of Ethanol Hepatotoxicity.
‡9
1
|
|
919
|
|
|
‡a
shortandlongtermdistributionandtoxicityofgoldnanoparticlesintheratafterasingledoseintravenousadministration
‡A
Short- and long-term distribution and toxicity of gold nanoparticles in the rat after a single-dose intravenous administration
‡9
1
|
|
919
|
|
|
‡a
severaltransportsystemscontributetotheintestinaluptakeofparaquatmodulatingitscytotoxiceffects
‡A
Several transport systems contribute to the intestinal uptake of Paraquat, modulating its cytotoxic effects.
‡9
1
|
|
919
|
|
|
‡a
selectivedeterminationofchromium6inpowderedmilkinfantformulasbyelectrothermalatomizationatomicabsorptionspectrometryafterionexchange
‡A
Selective determination of chromium (VI) in powdered milk infant formulas by electrothermal atomization atomic absorption spectrometry after ion exchange
‡9
1
|
|
919
|
|
|
‡a
selectivedeterminationofchromium
‡A
Selective determination of chromium
‡9
1
|
|
919
|
|
|
‡a
scientificopiniononthesafetyandefficacyofaviax5semduramicinsodiumforchickensforfattening
‡A
Scientific Opinion on the safety and efficacy of Aviax 5% (semduramicin sodium) for chickens for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyofzincchelateofmethioninesulfateforthetargetspecies
‡A
Safety of zinc chelate of methionine sulfate for the target species
‡9
1
|
|
919
|
|
|
‡a
safetyofvitamind3additiontofeedingstuffsforfish
‡A
Safety of vitamin D3 addition to feedingstuffs for fish
‡9
1
|
|
919
|
|
|
‡a
safetyofvitaminb280asriboflavinproducedbybacillussubtiliskccm10445forallanimalspecies
‡A
Safety of vitamin B2 (80%) as riboflavin produced by Bacillus subtilis KCCM-10445 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyofvitaminbsub12subintheformofcyanocobalaminproducedby1ensiferadhaerens1cncm15541forallanimalspecies
‡A
Safety of vitamin B<sub>12</sub> (in the form of cyanocobalamin) produced by <i>Ensifer adhaerens</i>CNCM-I 5541 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyofpotassiumdiformateformitmlhsasafeedadditiveforsowsfromaddconeuropegmbh
‡A
Safety of potassium diformate (Formi™ LHS) as a feed additive for sows, from ADDCON EUROPE GmbH
‡9
1
|
|
919
|
|
|
‡a
safetyofnaturalmixtureofillitemontmorilloniteandkaoliniteargileverteduvelayforallanimalspecies
‡A
Safety of natural mixture of illite, montmorillonite and kaolinite (Argile Verte du Velay) for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyofnaturalmixtureofdolomiteplusmagnesiteandmagnesiumphyllosilicatesfluidolforallanimalspecies
‡A
Safety of natural mixture of dolomite plus magnesite and magnesium-phyllosilicates (Fluidol) for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyofnaturalmixtureofdolomiteplusmagnesiteandmagnesiumphyllosilicates
‡A
Safety of natural mixture of dolomite plus magnesite and magnesium‐phyllosilicates
‡9
1
|
|
919
|
|
|
‡a
safetyofmethanethiolwhenusedasafeedadditiveforallanimalspecies
‡A
Safety of methanethiol [12.003] when used as a feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyoflignosulphonateforallanimalspecies
‡A
Safety of lignosulphonate for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyoflancerlanthanidecitrateasazootechnicaladditiveforweanedpiglets
‡A
Safety of Lancer® (lanthanide citrate) as a zootechnical additive for weaned piglets
‡9
1
|
|
919
|
|
|
‡a
safetyoflactococcuslactisncimb30160asafeedadditiveforallanimalspecies
‡A
Safety of Lactococcus lactis NCIMB 30160 as a feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyoflacticacidandcalciumlactatewhenusedastechnologicaladditivesforallanimalspecies
‡A
Safety of lactic acid and calcium lactate when used as technological additives for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyof50tryptophantechnicallypureproducedbyfermentationwithescherichiacolidsm25084kccm11132pandsari12091203forallanimalspeciesbasedonadossiersubmittedbyfefanaasbl
‡A
Safety of l‐tryptophan technically pure, produced by fermentation with Escherichia coli DSM 25084, KCCM 11132P and SARI12091203 for all animal species based on a dossier submitted by FEFANA Asbl
‡9
1
|
|
919
|
|
|
‡a
safetyof50tryptophantechnicallypureproducedbyescherichiacolicgmcc3667forallanimalspeciesbasedonadossiersubmittedbygbteuropegmbh
‡A
Safety of l‐tryptophan technically pure, produced by Escherichia coli CGMCC 3667, for all animal species based on a dossier submitted by GBT Europe GmbH
‡9
1
|
|
919
|
|
|
‡a
safetyof50tryptophanproducedusingescherichiacolicgmcc11674forallanimalspecies
‡A
Safety of l-tryptophan produced using Escherichia coli CGMCC 11674 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyof50threonineproducedbyfermentationwithescherichiacolicgmcc11473asafeedadditiveforallanimalspecies
‡A
Safety of l-threonine produced by fermentation with Escherichia coli CGMCC 11473 as a feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyof50lysinesulfateproducedbyfermentationwithescherichiacolicgmcc3705forallanimalspecies
‡A
Safety of l‐lysine sulfate produced by fermentation with Escherichia coli CGMCC 3705 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyofhexamethylenetetramineforpigspoultrybovinessheepgoatsrabbitsandhorses
‡A
Safety of hexamethylene tetramine for pigs, poultry, bovines, sheep, goats, rabbits and horses
‡9
1
|
|
919
|
|
|
‡a
safetyofethylesterofβapo8carotenoicacidasafeedadditiveforpoultryforfatteningandpoultryforlaying
‡A
Safety of ethyl ester of β-apo-8'-carotenoic acid as a feed additive for poultry for fattening and poultry for laying
‡9
1
|
|
919
|
|
|
‡a
safetyoferythrosineforornamentalfish
‡A
Safety of erythrosine for ornamental fish
‡9
1
|
|
919
|
|
|
‡a
safetyofendofeed600endo134βglucanaseandendo14βxylanaseasafeedadditiveforchickensforfatteninglayinghenspigsforfatteningandminorpoultryandporcinespecies
‡A
Safety of Endofeed® DC (endo‐1,3(4)‐β‐glucanase and endo‐1,4‐β‐xylanase) as a feed additive for chickens for fattening, laying hens, pigs for fattening and minor poultry and porcine species
‡9
1
|
|
919
|
|
|
‡a
safetyofconcentrated50lysinebase50lysinemonohydrochlorideand50lysinesulfateproducedusingdifferentstrainsofcorynebacteriumglutamicumforallanimalspeciesbasedonadossiersubmittedbyfefanaasbl
‡A
Safety of concentrated l‐lysine (base), l‐lysine monohydrochloride and l‐lysine sulfate produced using different strains of Corynebacterium glutamicum for all animal species based on a dossier submitted by FEFANA asbl
‡9
1
|
|
919
|
|
|
‡a
safetyofcassiagumasafeedadditivefordogsandcatsbasedonadossiersubmittedbyintercolloidukltd
‡A
Safety of cassia gum as a feed additive for dogs and cats based on a dossier submitted by Intercolloid (UK) Ltd
‡9
1
|
|
919
|
|
|
‡a
safetyofcassiagumasafeedadditivefordogsandcatsbasedonadossiersubmittedbyintercolloid
‡A
Safety of cassia gum as a feed additive for dogs and cats based on a dossier submitted by Intercolloid
‡9
1
|
|
919
|
|
|
‡a
safetyofcassiagumasafeedadditivefordogsandcatsbasedonadossiersubmittedbyglycomergmbh
‡A
Safety of cassia gum as a feed additive for dogs and cats based on a dossier submitted by Glycomer GmbH
‡9
1
|
|
919
|
|
|
‡a
safetyofcassiagumasafeedadditiveforcatsanddogsbasedonadossiersubmittedbyglycomergmbh
‡A
Safety of cassia gum as a feed additive for cats and dogs based on a dossier submitted by Glycomer GmbH
‡9
1
|
|
919
|
|
|
‡a
safetyofbutylatedhydroxyanisolebhaforallanimalspecies
‡A
Safety of butylated hydroxy anisole (BHA) for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyofanessentialoilfromoriganumvulgaresubsphirtumlinkletswvarvulkanwhenusedasasensoryadditiveinfeedforallanimalspecies
‡A
Safety of an essential oil from Origanum vulgare subsp. hirtum (Link) letsw. var. Vulkan when used as a sensory additive in feed for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyofammoniumformatee295forallanimalspecies
‡A
Safety of ammonium formate (E 295) for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyofatincturederivedfromartemisiavulgaris50mugworttincturewhenusedasasensoryadditiveinfeedforallanimalspecies
‡A
Safety of a tincture derived from Artemisia vulgaris L. (Mugwort tincture) when used as a sensory additive in feed for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyof31flavouringcompoundsbelongingtodifferentchemicalgroupswhenusedasfeedadditivesforallanimalspecies
‡A
Safety of 31 flavouring compounds belonging to different chemical groups when used as feed additives for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyof3phytaseflf1000andfsf10000asafeedadditiveforpigsforfatteningandminorgrowingporcinespecies
‡A
Safety of 3-phytase FLF1000 and FSF10000 as a feed additive for pigs for fattening and minor growing porcine species
‡9
1
|
|
919
|
|
|
‡a
safetyfortheenvironmentofvitamind3forsalmonids
‡A
Safety for the environment of vitamin D3 for salmonids
‡9
1
|
|
919
|
|
|
‡a
safetyfortheenvironmentofsorbitanmonolaurateasafeedadditiveforallanimalspecies
‡A
Safety for the environment of sorbitan monolaurate as a feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyfortheenvironmentofmonimaxmonensinsodiumandnicarbazinforchickensforfatteningchickensrearedforlayingandforturkeysforfattening
‡A
Safety for the environment of Monimax® (monensin sodium and nicarbazin) for chickens for fattening, chickens reared for laying and for turkeys for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandnutritionalvalueofadriedkilledbacterialbiomassfromescherichiacolifermbp10942pt73tmasafeedmaterialforpigsruminantsandsalmonids
‡A
Safety and nutritional value of a dried killed bacterial biomass from Escherichia coli (FERM BP‐10942) (PT73 (TM)) as a feed material for pigs, ruminants and salmonids
‡9
1
|
|
919
|
|
|
‡a
safetyandnutritionalvalueofadriedkilledbacterialbiomassfromescherichiacolifermbp10941pl73lmasafeedmaterialforpigsruminantsandsalmonids
‡A
Safety and nutritional value of a dried killed bacterial biomass from Escherichia coli (FERM BP‐10941) (PL73 (LM)) as a feed material for pigs, ruminants and salmonids
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofzm1610bacillusamyloliquefaciensdsm25840asafeedadditiveforweanedpigletsandminorporcinespecies
‡A
Safety and efficacy of ZM16 10 (Bacillus amyloliquefaciens DSM 25840) as a feed additive for weaned piglets and minor porcine species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofzm1610bacillusamyloliquefaciensdsm25840asafeedadditiveforsowsinordertohavebenefitsinpigletssowsforreproductionpigletssucklingandweanedpigsforfatteningandminorporcinespecies
‡A
Safety and efficacy of ZM16 10 (Bacillus amyloliquefaciens DSM 25840) as a feed additive for sows in order to have benefits in piglets, sows for reproduction, piglets (suckling and weaned), pigs for fattening and minor porcine species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofzinc50selenomethionineasfeedadditiveforallanimalspecies
‡A
Safety and efficacy of Zinc-l-Selenomethionine as feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofzincchelatesoflysineandglutamicacidasfeedadditiveforallanimalspecies
‡A
Safety and efficacy of zinc chelates of lysine and glutamic acid as feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofzincchelateofmethioninesulfateforallanimalspecies
‡A
Safety and efficacy of zinc chelate of methionine sulfate for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofvitaminb2riboflavinproducedbyashbyagossypiiforallanimalspeciesbasedonadossiersubmittedbybasfse
‡A
Safety and efficacy of vitamin B2 (riboflavin) produced by Ashbya gossypii ■■■■■ for all animal species based on a dossier submitted by BASF SE
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofvitaminb2riboflavin5phosphateestermonosodiumsaltforallanimalspecieswhenusedinwaterfordrinking
‡A
Safety and efficacy of vitamin B2 (riboflavin 5'-phosphate ester monosodium salt) for all animal species when used in water for drinking
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofvitaminb12intheformofcyanocobalaminproducedbyensifersppasafeedadditiveforallanimalspeciesbasedonadossiersubmittedbyvitaceeig
‡A
Safety and efficacy of vitamin B12 (in the form of cyanocobalamin) produced by Ensifer spp. as a feed additive for all animal species based on a dossier submitted by VITAC EEIG
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofvevovitallbenzoicacidasfeedadditiveforpigsforfattening
‡A
Safety and efficacy of VevoVitall® (benzoic acid) as feed additive for pigs for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofvevovitallbenzoicacidasfeedadditiveforminorporcinespecies
‡A
Safety and efficacy of VevoVitall® (benzoic acid) as feed additive for minor porcine species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofvevovitall
‡A
Safety and efficacy of VevoVitall®
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofvermiculiteasafeedadditiveforpigspoultrybovinessheepgoatsrabbitsandhorses
‡A
Safety and efficacy of vermiculite as a feed additive for pigs, poultry, bovines, sheep, goats, rabbits and horses
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoftyfertmferrictyrosinechelateasazootechnicalfeedadditiveforchickensturkeysandminorpoultryspeciesforfatteningorrearedforlayingbreeding
‡A
Safety and efficacy of TYFER™ (ferric tyrosine chelate) as a zootechnical feed additive for chickens, turkeys and minor poultry species for fattening or reared for laying/breeding
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofturmericextractturmericoilturmericoleoresinandturmerictincturefromcurcumalonga50rhizomewhenusedassensoryadditivesinfeedforallanimalspecies
‡A
Safety and efficacy of turmeric extract, turmeric oil, turmeric oleoresin and turmeric tincture from Curcuma longa L. rhizome when used as sensory additives in feed for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoftechnosporebacilluscoagulansdsm32016forpigletsothergrowingsuidaechickensforfatteningotherpoultryforfatteningandornamentalbirds
‡A
Safety and efficacy of TechnoSpore® (Bacillus coagulans DSM 32016) for piglets, other growing Suidae, chickens for fattening, other poultry for fattening and ornamental birds
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoftaminizer500dimethylglycinesodiumsaltasafeedadditiveforchickensforfattening
‡A
Safety and efficacy of Taminizer D (dimethylglycine sodium salt) as a feed additive for chickens for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofstenorolahalofuginonehydrobromideasafeedadditiveforchickensforfatteningandturkeys
‡A
Safety and efficacy of STENOROL® (halofuginone hydrobromide) as a feed additive for chickens for fattening and turkeys
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofstenorolhalofuginonehydrobromideasafeedadditiveforchickensforfatteningandturkeys
‡A
Safety and efficacy of STENOROL® (halofuginone hydrobromide) as a feed additive for chickens for fattening and turkeys
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofstabilflorasazootechnicalfeedadditiveforpigsforfattening
‡A
Safety and efficacy of STABILFLOR® as a zootechnical feed additive for pigs for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofsorbitanmonolaurateasafeedadditiveforallanimalspecies
‡A
Safety and efficacy of sorbitan monolaurate as a feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofsodiumselenateasfeedadditiveforruminants
‡A
Safety and efficacy of sodium selenate as feed additive for ruminants
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofsodiumsaccharinwhenusedasafeedflavourforpigletspigsforfatteningcalvesforrearingandcalvesforfattening
‡A
Safety and efficacy of sodium saccharin when used as a feed flavour for piglets, pigs for fattening, calves for rearing and calves for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofsodiumcarboxymethylcelluloseforallanimalspecies
‡A
Safety and efficacy of sodium carboxymethyl cellulose for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofsodiumandpotassiumalginateforpetsothernonfoodproducinganimalsandfish
‡A
Safety and efficacy of sodium and potassium alginate for pets, other non food‐producing animals and fish
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofseleniumenrichedyeastsaccharomycescerevisiaecncm13399forallanimalspecies
‡A
Safety and efficacy of selenium‐enriched yeast (Saccharomyces cerevisiae CNCM I‐3399) for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofseleniumenrichedyeast
‡A
Safety and efficacy of selenium‐enriched yeast
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofsaponifiedpaprikaextractcontainingcapsanthinasmaincarotenoidsourceforpoultryforfatteningandlayingexceptturkeys
‡A
Safety and efficacy of saponified paprika extract, containing capsanthin as main carotenoid source, for poultry for fattening and laying (except turkeys)
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofsacoxmicrogranulatesalinomycinsodiumforrabbitsforfattening
‡A
Safety and efficacy of Sacox® microGranulate (salinomycin sodium) for rabbits for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofsacoxmicrogranulatesalinomycinsodiumforchickensforfatteningandchickensrearedforlaying
‡A
Safety and efficacy of Sacox® microGranulate (salinomycin sodium) for chickens for fattening and chickens reared for laying
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofsacoxmicrogranulate
‡A
Safety and efficacy of Sacox® microGranulate
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofronozymewxendo14βxylanaseasafeedadditiveforlayinghens
‡A
Safety and efficacy of RONOZYME® WX (endo‐1,4‐β‐xylanase) as a feed additive for laying hens
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofronozymewxct50endo14βxylanaseasafeedadditiveforsowsforreproduction
‡A
Safety and efficacy of RONOZYME®WX CT/L (endo-1,4-β-xylanase) as a feed additive for sows for reproduction
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofrobenz66grobenidinehydrochlorideforchickensforfatteningandturkeysforfattening
‡A
Safety and efficacy of Robenz® 66G (robenidine hydrochloride) for chickens for fattening and turkeys for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofpyrazinederivativesincludingsaturatedonesbelongingtochemicalgroup24whenusedasflavouringsforallanimalspecies
‡A
Safety and efficacy of pyrazine derivatives including saturated ones belonging to chemical group 24 when used as flavourings for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofpropylgallateforallanimalspecies
‡A
Safety and efficacy of propyl gallate for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofprobioticlactinaenterococcusfaeciumnbimcc8270lactobacillusacidophilusnbimcc8242lactobacillushelveticusnbimcc8269lactobacillusdelbrueckiissplactisnbimcc8250lactobacillusdelbrueckiisspbulgaricusnb
‡A
Safety and efficacy of Probiotic Lactina® (Enterococcus faecium NBIMCC 8270, Lactobacillus acidophilus NBIMCC 8242, Lactobacillus helveticus NBIMCC 8269, Lactobacillus delbrueckii ssp. lactis NBIMCC 8250, Lactobacillus delbrueckii ssp. bulgaricus NB
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofprobionfortebacillussubtiliskccm10941pandbacilluscoagulanskccm11093pforchickensforfattening
‡A
Safety and efficacy of Probion forte® (Bacillus subtilis KCCM 10941P and Bacillus coagulans KCCM 11093P) for chickens for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofprobionfortebacillussubtiliskccm10941pandbacilluscoagulanskccm11093pasafeedadditiveforchickensforfattening
‡A
Safety and efficacy of Probion Forte® (Bacillus subtilis KCCM 10941P and Bacillus coagulans KCCM 11093P) as a feed additive for chickens for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofprobionforte
‡A
Safety and efficacy of Probion Forte®
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofponceau4rforcatsdogsandornamentalfish
‡A
Safety and efficacy of ponceau 4R for cats, dogs and ornamental fish
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofpediococcuspentosaceusdsm32291asasilageadditiveforallanimalspecies
‡A
Safety and efficacy of Pediococcus pentosaceus DSM 32291 as a silage additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofpediococcusparvulusdsm28875asasilageadditiveforallanimalspecies
‡A
Safety and efficacy of Pediococcus parvulus DSM 28875 as a silage additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofpanavitalfeed500glycericacidforchickensforfattening
‡A
Safety and efficacy of Panavital feed (d-glyceric acid) for chickens for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofoptiphosplusforsucklingandweanedpigletspigsforfatteningsowsotherminorpigspeciesforfatteningandotherminorreproductivepigspecies
‡A
Safety and efficacy of OptiPhos®PLUS for suckling and weaned piglets, pigs for fattening, sows, other minor pig species for fattening and other minor reproductive pig species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofoptiphosplusforpoultryspeciesforfatteningminorpoultryspeciesrearedforbreedingandornamentalbirds
‡A
Safety and efficacy of OptiPhos® PLUS for poultry species for fattening, minor poultry species reared for breeding and ornamental birds
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofoptiphosplus6phytaseforlayinghensturkeysforbreedingchickensforbreedingminorpoultryspeciesforeggproductionpurposesandbreeding
‡A
Safety and efficacy of OptiPhos®PLUS (6 phytase) for laying hens, turkeys for breeding, chickens for breeding, minor poultry species for egg production purposes and breeding
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofoptiphos6phytaseasafeedadditiveforfinfish
‡A
Safety and efficacy of OPTIPHOS® (6‐phytase) as a feed additive for finfish
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofoptiphos
‡A
Safety and efficacy of OPTIPHOS®
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofoct1en3olpent1en3oloct1en31oct1en3ylacetateisopulegoland5methylhept2en41belongingtochemicalgroup5andofisopulegoneandαdamasconebelongingtochemicalgroup8whenusedasflavouri
‡A
Safety and efficacy of oct-1-en-3-ol, pent-1-en-3-ol, oct-1-en-3-one, oct-1-en-3-yl acetate, isopulegol and 5-methylhept-2-en-4-one, belonging to chemical group 5 and of isopulegone and α-damascone belonging to chemical group 8 when used as flavouri
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofnutrasep6phytaseforchickensforfatteningotherpoultryforfatteningrearedforlayingandornamentalbirds
‡A
Safety and efficacy of Nutrase P (6-phytase) for chickens for fattening, other poultry for fattening, reared for laying and ornamental birds
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofnimicoatcarvacrolasazootechnicaladditiveforweanedpiglets
‡A
Safety and efficacy of Nimicoat® (carvacrol) as a zootechnical additive for weaned piglets
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofnaturalmixturesoftalcsteatiteandchloritee560asafeedadditiveforallanimalspecies
‡A
Safety and efficacy of natural mixtures of talc (steatite) and chlorite (E 560) as a feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofnaturalmixtureofillitemontmorilloniteandkaoliniteforallanimalspecies
‡A
Safety and efficacy of natural mixture of illite, montmorillonite and kaolinite for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofnatuphose6phytaseasafeedadditiveforlayinghensminorpoultryandotheravianspeciesforlaying
‡A
Safety and efficacy of Natuphos® E (6-phytase) as a feed additive for laying hens, minor poultry and other avian species for laying
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofnatuphose6phytaseasafeedadditiveforavianandporcinespecies
‡A
Safety and efficacy of Natuphos® E (6‐phytase) as a feed additive for avian and porcine species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofnatuphose
‡A
Safety and efficacy of Natuphos® E
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofnatugraintsts50endo14betaxylanaseandendo14betaglucanaseasafeedadditiveforsows
‡A
Safety and efficacy of Natugrain®TS/TS L (endo-1,4-beta-xylanase and endo-1,4-beta-glucanase) as a feed additive for sows
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofmuramidasefromtrichodermareeseidsm32338asafeedadditiveforturkeysforfatteningturkeysrearedforbreedingchickensrearedforbreedingandotherpoultryspeciesrearedforbreeding
‡A
Safety and efficacy of muramidase from Trichoderma reesei DSM 32338 as a feed additive for turkeys for fattening, turkeys reared for breeding, chickens reared for breeding and other poultry species reared for breeding
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofmuramidasefromtrichodermareeseidsm32338asafeedadditiveforchickensforfatteningandminorpoultryspecies
‡A
Safety and efficacy of muramidase from Trichoderma reesei DSM 32338 as a feed additive for chickens for fattening and minor poultry species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofmontebang100narasinforducksforfattening
‡A
Safety and efficacy of Monteban® G100 (narasin) for ducks for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofmontebang100narasinforchickensforfattening
‡A
Safety and efficacy of Monteban® G100 (narasin) for chickens for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofmonosodium50glutamatemonohydrateproducedbycorynebacteriumglutamicumkccm80188asafeedadditiveforallanimalspecies
‡A
Safety and efficacy of monosodium l-glutamate monohydrate produced by Corynebacterium glutamicum KCCM 80188 as a feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofmonimaxmonensinsodiumandnicarbazinforturkeysforfattening
‡A
Safety and efficacy of Monimax® (monensin sodium and nicarbazin) for turkeys for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofmonimaxmonensinsodiumandnicarbazinforchickensforfatteningandchickensrearedforlaying
‡A
Safety and efficacy of Monimax® (monensin sodium and nicarbazin) for chickens for fattening and chickens reared for laying
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofmicroorganismdsm11798asatechnologicaladditiveforallavianspecies
‡A
Safety and efficacy of microorganism DSM 11798 as a technological additive for all avian species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofmicrocrystallinecelluloseforallanimalspecies
‡A
Safety and efficacy of microcrystalline cellulose for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofmethylcelluloseforallanimalspecies
‡A
Safety and efficacy of methyl cellulose for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofmanganesechelatesoflysineandglutamicacidasfeedadditiveforallanimalspecies
‡A
Safety and efficacy of Manganese chelates of lysine and glutamic acid as feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofluteinandluteinzeaxanthinextractsfromtageteserectaforpoultryforfatteningandlayingexceptturkeys
‡A
Safety and efficacy of lutein and lutein/zeaxanthin extracts from Tagetes erecta for poultry for fattening and laying (except turkeys)
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflevucellscsaccharomycescerevisiaecncm11077asafeedadditivefordairycowscattleforfatteningminorruminantspeciesandcamelids
‡A
Safety and efficacy of Levucell® SC (Saccharomyces cerevisiae CNCM I‐1077) as a feed additive for dairy cows, cattle for fattening, minor ruminant species and camelids
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflevucellscsaccharomycescerevisiaecncm11077asafeedadditiveforcalvesandminorruminantspeciesandcamelidsatthesamedevelopmentalstage
‡A
Safety and efficacy of Levucell SC® (Saccharomyces cerevisiae CNCM I-1077) as a feed additive for calves and minor ruminant species and camelids at the same developmental stage
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflevucellsbsaccharomycescerevisiaecncm11079asafeedadditiveforturkeysforfattening
‡A
Safety and efficacy of Levucell®SB (Saccharomyces cerevisiae CNCM I-1079) as a feed additive for turkeys for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflevucellsbsaccharomycescerevisiaecncm11079asafeedadditiveforchickensforfatteningandminorpoultryspecies
‡A
Safety and efficacy of Levucell® SB (Saccharomyces cerevisiae CNCM I‐1079) as a feed additive for chickens for fattening and minor poultry species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflevucellsbsaccharomycescerevisiaecncm11079asafeedadditiveforallpigs
‡A
Safety and efficacy of Levucell®SB (Saccharomyces cerevisiae CNCM I-1079) as a feed additive for all pigs
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflevucellsb
‡A
Safety and efficacy of Levucell® SB
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflactobacillusrhamnosusdsm29226asasilageadditiveforallanimalspecies
‡A
Safety and efficacy of Lactobacillus rhamnosus DSM 29226 as a silage additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflactobacillusrhamnosuscncm13698andlactobacillusfarciminiscncm13699asafeedadditiveforallanimalspecies
‡A
Safety and efficacy of Lactobacillus rhamnosus CNCM I-3698 and Lactobacillus farciminis CNCM I-3699 as a feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflactobacillusreuterinbf2dsm32264asafeedadditiveforcats
‡A
Safety and efficacy of Lactobacillus reuteri NBF-2 (DSM 32264) as a feed additive for cats
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflactobacillusreuterinbf1dsm32203asafeedadditivefordogs
‡A
Safety and efficacy of Lactobacillus reuteri NBF-1 (DSM 32203) as a feed additive for dogs
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflactobacillusplantarumdsm29024asasilageadditiveforallanimalspecies
‡A
Safety and efficacy of Lactobacillus plantarum DSM 29024 as a silage additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflactobacillusparafarraginisdsm32962asasilageadditiveforallanimalspecies
‡A
Safety and efficacy of Lactobacillus parafarraginis DSM 32962 as a silage additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflactobacillushilgardiicncm14785asasilageadditiveforallanimalspecies
‡A
Safety and efficacy of Lactobacillus hilgardii CNCM I‐4785 as a silage additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflactobacilluscaseidsm28872asasilageadditiveforallanimalspecies
‡A
Safety and efficacy of Lactobacillus casei DSM 28872 as a silage additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflactobacillusbuchnerinrrlb50733asasilageadditiveforallanimalspecies
‡A
Safety and efficacy of Lactobacillus buchneri NRRL B‐50733 as a silage additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflactobacillusbuchneridsm29026asasilageadditiveforallanimalspecies
‡A
Safety and efficacy of Lactobacillus buchneri DSM 29026 as a silage additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflactobacillusacidophilusd2csllactobacillusacidophiluscect4529asafeedadditiveforchickensforfattening
‡A
Safety and efficacy of Lactobacillus acidophilus D2/CSL (Lactobacillus acidophilus CECT 4529) as a feed additive for chickens for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflactobacillusacidophilusd2csllactobacillusacidophiluscect4529asafeedadditiveforcatsanddogs
‡A
Safety and efficacy of Lactobacillus acidophilus D2/CSL (Lactobacillus acidophilus CECT 4529) as a feed additive for cats and dogs
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoflactobacillusacidophilusd2csl
‡A
Safety and efficacy of Lactobacillus acidophilus D2/CSL
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50valineproducedusingcorynebacteriumglutamicumcgmcc11675forallanimalspecies
‡A
Safety and efficacy of l-valine produced using Corynebacterium glutamicum CGMCC 11675 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50valineproducedbyfermentationusingescherichiacolikccm80159forallanimalspecies
‡A
Safety and efficacy of l-valine produced by fermentation using Escherichia coli KCCM 80159 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50valineproducedbyfermentationusingcorynebacteriumglutamicumcgmcc7358asafeedadditiveforallanimalspecies
‡A
Safety and efficacy of l-valine produced by fermentation using Corynebacterium glutamicumCGMCC 7.358 as a feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50valineproducedbyfermentationusingcorynebacteriumglutamicumkccm11201pforallanimalspecies
‡A
Safety and efficacy of l-valine produced by fermentation using Corynebacterium glutamicum KCCM 11201P for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50tryptophanproducedwithescherichiacolicgmcc11674forallanimalspecies
‡A
Safety and efficacy of l-tryptophan produced with Escherichia coli CGMCC 11674 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50tryptophanproducedbyfermentationwithescherichiacolikccm80152forallanimalspecies
‡A
Safety and efficacy of l-tryptophan produced by fermentation with Escherichia coli KCCM 80152 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50tryptophanproducedbyfermentationwithescherichiacolikccm80135forallanimalspecies
‡A
Safety and efficacy of l-tryptophan produced by fermentation with Escherichia coli KCCM 80135 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50tryptophanproducedbyfermentationwithescherichiacolikccm10534forallanimalspecies
‡A
Safety and efficacy of l-tryptophan produced by fermentation with Escherichia coli KCCM 10534 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50tryptophanproducedbyfermentationwithescherichiacolicgmcc7248forallanimalspecies
‡A
Safety and efficacy of l-tryptophan produced by fermentation with Escherichia coli CGMCC 7.248 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50tryptophanproducedbyfermentationwithcorynebacteriumglutamicumkccm80176forallanimalspecies
‡A
Safety and efficacy of l-tryptophan produced by fermentation with Corynebacterium glutamicum KCCM 80176 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50tryptophanproducedbyfermentationusingescherichiacolicgmcc7267forallanimalspecies
‡A
Safety and efficacy of l-tryptophan produced by fermentation using Escherichia coli CGMCC 7.267 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50threonineproducedusing1escherichiacoli1cgmcc13325asafeedadditiveforallanimalspecies
‡A
Safety and efficacy of l-threonine produced using <i>Escherichia coli</i>CGMCC 13325 as a feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50threonineproducedbyfermentationwithescherichiacolicgmcc11473forallanimalspecies
‡A
Safety and efficacy of l‐threonine produced by fermentation with Escherichia coli CGMCC 11473 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50threonineproducedbyfermentationwithcorynebacteriumglutamicumforallanimalspecies
‡A
Safety and efficacy of l-threonine produced by fermentation with Corynebacterium glutamicum ■■■■■ for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50methionineproducedbyfermentationwithcorynebacteriumglutamicumkccm80184andescherichiacolikccm80096forallanimalspecies
‡A
Safety and efficacy of l-methionine produced by fermentation with Corynebacterium glutamicum KCCM 80184 and Escherichia coli KCCM 80096 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50lysinesulfateproducedbyfermentationusingcorynebacteriumglutamicumkfcc11043asafeedadditiveforallanimalspecies
‡A
Safety and efficacy of l-lysine sulfate produced by fermentation using Corynebacterium glutamicum KFCC 11043 as a feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50lysinemonohydrochlorideproducedbyfermentationwithcorynebacteriumglutamicumdsm32932forallanimalspecies
‡A
Safety and efficacy of l-lysine monohydrochloride produced by fermentation with Corynebacterium glutamicum DSM 32932 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50lysinemonohydrochlorideand50lysinesulfateproducedusingcorynebacteriumglutamicumcgmcc7266forallanimalspecies
‡A
Safety and efficacy of l-lysine monohydrochloride and l-lysine sulfate produced using Corynebacterium glutamicum CGMCC 7.266 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50lysinemonohydrochlorideand50lysinesulfateproducedusingcorynebacteriumglutamicumcctcc10002015595forallanimalspecies
‡A
Safety and efficacy of l-lysine monohydrochloride and l-lysine sulfate produced using Corynebacterium glutamicum CCTCC M 2015595 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50lysinemonohydrochlorideandconcentratedliquid50lysinebaseproducedbyfermentationwith1corynebacteriumglutamicum1kctc12307bpasfeedadditivesforallanimalspecies
‡A
Safety and efficacy of l-lysine monohydrochloride and concentrated liquid l-lysine (base) produced by fermentation with <i>Corynebacterium glutamicum</i>KCTC 12307BP as feed additives for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50lysinemonohydrochlorideandconcentratedliquid50lysinebaseproducedbyfermentationwith1corynebacteriumglutamicum1kccm80216asfeedadditiveforallanimalspecies
‡A
Safety and efficacy of l-lysine monohydrochloride and concentrated liquid l-lysine (base) produced by fermentation with <i>Corynebacterium glutamicum</i> KCCM 80216 as feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50lysinemonohydrochlorideandconcentratedliquid50lysinebaseproducedbyfermentationusingcorynebacteriumglutamicumstrainsnrrlb67439ornrrlb67535forallanimalspecies
‡A
Safety and efficacy of l-lysine monohydrochloride and concentrated liquid l-lysine (base) produced by fermentation using Corynebacterium glutamicum strains NRRL-B-67439 or NRRL B-67535 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50lysinemonohydrochlorideandconcentratedliquid50lysinebaseproducedbyfermentationusingcorynebacteriumglutamicumstrainnrrlb50775forallanimalspeciesbasedonadossiersubmittedbyadm
‡A
Safety and efficacy of l-lysine monohydrochloride and concentrated liquid l-lysine (base) produced by fermentation using Corynebacterium glutamicum strain NRRL B-50775 for all animal species based on a dossier submitted by ADM
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50lysinemonohydrochlorideandconcentratedliquid50lysinebaseproducedbyfermentationusingcorynebacteriumglutamicumstrainkccm10227forallanimalspecies
‡A
Safety and efficacy of l-lysine monohydrochloride and concentrated liquid l-lysine (base) produced by fermentation using Corynebacterium glutamicum strain KCCM 10227 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50leucineproducedbyfermentationwithescherichiacolinitebp02351forallanimalspecies
‡A
Safety and efficacy of l-leucine produced by fermentation with Escherichia coli NITE BP-02351 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50isoleucineproducedbyfermentationwithcorynebacteriumglutamicumkccm80189forallanimalspecies
‡A
Safety and efficacy of l-isoleucine produced by fermentation with Corynebacterium glutamicum KCCM 80189 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50histidinemonohydrochloridemonohydrateproducedusingcorynebacteriumglutamicumkccm80179forallanimalspecies
‡A
Safety and efficacy of l-histidine monohydrochloride monohydrate produced using Corynebacterium glutamicum KCCM 80179 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50histidinemonohydrochloridemonohydrateproducedusingcorynebacteriumglutamicumkccm80172forallanimalspecies
‡A
Safety and efficacy of l-histidine monohydrochloride monohydrate produced using Corynebacterium glutamicum KCCM 80172 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50histidinemonohydrochloridemonohydrateproducedbyfermentationwithescherichiacolinitebp02526forallanimalspecies
‡A
Safety and efficacy of l-histidine monohydrochloride monohydrate produced by fermentation with Escherichia coli (NITE BP-02526) for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50histidinemonohydrochloridemonohydrateproducedbyfermentationusingescherichiacolikccm80212asafeedadditiveforallanimalspecies
‡A
Safety and Efficacy of l-histidine monohydrochloride monohydrate produced by fermentation using Escherichia coli KCCM 80212 as a feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50glutamineproducedusingcorynebacteriumglutamicumnitebp02524forallanimalspecies
‡A
Safety and efficacy of l-glutamine produced using Corynebacterium glutamicum NITE BP-02524 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50cystineproducedusingpantoeaananatisstrainnitebp02525forallanimalspecies
‡A
Safety and efficacy of l-cystine produced using Pantoea ananatis strain NITE BP-02525 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50cysteinemonohydrochloridemonohydrateproducedbyfermentationusingescherichiacolikccm80109andescherichiacolikccm80197forallanimalspecies
‡A
Safety and efficacy of l-cysteine monohydrochloride monohydrate produced by fermentation using Escherichia coli KCCM 80109 and Escherichia coli KCCM 80197 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50cysteinehydrochloridemonohydrateproducedbyfermentationusingescherichiacolikccm80180andescherichiacolikccm80181asaflavouringadditiveforallanimalspecies
‡A
Safety and efficacy of l-cysteine hydrochloride monohydrate produced by fermentation using Escherichia coli KCCM 80180 and Escherichia coli KCCM 80181 as a flavouring additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50arginineproducedbyfermentationwithescherichiacolinitebp02186forallanimalspecies
‡A
Safety and efficacy of l-arginine produced by fermentation with Escherichia coli NITE BP-02186 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50arginineproducedbyfermentationwithcorynebacteriumglutamicumkccm80182forallanimalspecies
‡A
Safety and efficacy of l-arginine produced by fermentation with Corynebacterium glutamicum KCCM 80182 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50arginineproducedbyfermentationusingcorynebacteriumglutamicumkccm10741pforallanimalspecies
‡A
Safety and efficacy of l-arginine produced by fermentation using Corynebacterium glutamicum KCCM 10741P for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof50arginineproducedbycorynebacteriumglutamicumkccm80099forallanimalspecies
‡A
Safety and efficacy of l‐arginine produced by Corynebacterium glutamicum KCCM 80099 for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofkelforce50glutamicacidnndiaceticacidtetrasodiumsaltgldana4asafeedadditiveforchickensforfattening
‡A
Safety and efficacy of Kelforce® (l-glutamic acid, N,N-diacetic acid, tetrasodium salt (GLDA-Na4)) as a feed additive for chickens for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofirondextranasafeedadditiveforpiglets
‡A
Safety and efficacy of iron dextran as a feed additive for piglets
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofironchelatesoflysineandglutamicacidasfeedadditiveforallanimalspecies
‡A
Safety and efficacy of iron chelates of lysine and glutamic acid as feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofhydroxypropylmethylcelluloseforallanimalspecies
‡A
Safety and efficacy of hydroxypropyl methyl cellulose for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofhydroxypropylcelluloseforallanimalspecies
‡A
Safety and efficacy of hydroxypropyl cellulose for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofhydroxyanalogueofmethionineanditscalciumsaltadry+forallanimalspecies
‡A
Safety and efficacy of hydroxy analogue of methionine and its calcium salt (ADRY+®) for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofhostazym10endo14βxylanaseasafeedadditiveforchickensrearedforlayingandminorpoultryspeciesrearedforlaying
‡A
Safety and efficacy of HOSTAZYM® X (endo‐1,4‐β‐xylanase) as a feed additive for chickens reared for laying and minor poultry species reared for laying
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofhostazym10endo14βxylanaseasafeedadditiveforcarps
‡A
Safety and efficacy of HOSTAZYM® X (endo‐1,4‐β‐xylanase) as a feed additive for carps
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofhostazym10endo14betaxylanaseasafeedadditiveforrabbitsforfattening
‡A
Safety and efficacy of HOSTAZYM® X (endo-1,4-beta-xylanase) as a feed additive for rabbits for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofhemicell50endo14βmannanaseasafeedadditiveforchickensforfatteningorrearedforlayingturkeysforfatteningorrearedforbreedingandminorpoultryspecies
‡A
Safety and efficacy of Hemicell®-L (endo-1,4-β-mannanase) as a feed additive for chickens for fattening or reared for laying, turkeys for fattening or reared for breeding and minor poultry species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofhemicellhtendo14βmannanaseasafeedadditiveforchickensforfatteningchickensrearedforlayingturkeyforfatteningturkeysrearedforbreedingweanedpigletspigsforfatteningandminorpoultryandporcine
‡A
Safety and efficacy of Hemicell® HT (endo-1,4-β-mannanase) as a feed additive for chickens for fattening, chickens reared for laying, turkey for fattening, turkeys reared for breeding, weaned piglets, pigs for fattening and minor poultry and porcine
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofhemicellhtendo14β500mannanaseasafeedadditiveforchickensforfatteningchickensrearedforlayingturkeyforfatteningturkeysrearedforbreedingweanedpigletspigsforfatteningandminorpoultryandpor
‡A
Safety and efficacy of Hemicell® HT (endo‐1,4‐β‐d‐mannanase) as a feed additive for chickens for fattening, chickens reared for laying, turkey for fattening, turkeys reared for breeding, weaned piglets, pigs for fattening and minor poultry and por...
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofgalliprofitbacillussubtilisdsm32324bacillussubtilisdsm32325andbacillusamyloliquefaciensdsm25840forallpoultryspeciesforfatteningorrearedforlayingbreeding
‡A
Safety and efficacy of GalliPro® Fit (Bacillus subtilis DSM 32324, Bacillus subtilis DSM 32325 and Bacillus amyloliquefaciens DSM 25840) for all poultry species for fattening or reared for laying/breeding
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoffumonisinesterasefromkomagataellaphaffiidsm32159asatechnologicalfeedadditiveforpigsandpoultry
‡A
Safety and efficacy of fumonisin esterase from Komagataella phaffii DSM 32159 as a technological feed additive for pigs and poultry
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoffumonisinesterasefromkomagataellaphaffiidsm32159asafeedadditiveforallanimalspecies
‡A
Safety and efficacy of fumonisin esterase from Komagataella phaffii DSM 32159 as a feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoffsf10000andflf10003phytaseasafeedadditiveforturkeysforfatteningorrearedforbreedingpigsforfatteningandminorporcinespecies
‡A
Safety and efficacy of FSF10000 and FLF1000 (3-phytase) as a feed additive for turkeys for fattening or reared for breeding, pigs for fattening and minor porcine species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoffraoctazyme100dryαgalactosidaseαamylaseendo134βglucanaseendo14βglucanasemannanendo14βmannosidasepectinaseproteaseendo14βxylanaseforchickensforfatteningandweanedpiglets
‡A
Safety and efficacy of FRA® Octazyme C Dry (α‐galactosidase, α‐amylase, endo‐1,3(4)‐β‐glucanase, endo‐1,4‐β‐glucanase, mannan‐endo‐1,4‐β‐mannosidase, pectinase, protease, endo‐1,4‐β‐xylanase) for chickens for fattening and weaned piglets
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoffraoctazyme100dryendo14βxylanasemannanendo14βmannosidaseαamylaseendo134βglucanasepectinaseendo14βglucanaseproteaseαgalactosidaseasafeedadditiveforweanedpigletsandchickensforfa
‡A
Safety and efficacy of FRA® Octazyme C Dry (endo-1,4-β-xylanase, mannan-endo-1,4-β-mannosidase, α-amylase, endo-1,3(4)-β-glucanase, pectinase, endo-1,4-β-glucanase, protease, α-galactosidase) as a feed additive for weaned piglets and chickens for fa
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofethylcelluloseforallanimalspecies
‡A
Safety and efficacy of ethyl cellulose for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofessentialoiloleoresinandtincturefromzingiberofficinaleroscoewhenusedassensoryadditivesinfeedforallanimalspecies
‡A
Safety and efficacy of essential oil, oleoresin and tincture from Zingiber officinale Roscoe when used as sensory additives in feed for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofenzycarboplusendo14betaxylanaseandendo134betaglucanaseasafeedadditiveforavianspeciesweanedpigletsandminorweanedporcinespecies
‡A
Safety and efficacy of ENZY CARBOPLUS® (endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase) as a feed additive for avian species, weaned piglets and minor weaned porcine species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofelancobang200monensinsodiumforchickensforfatteningchickensrearedforlayingandturkeys
‡A
Safety and efficacy of Elancoban® G200 (monensin sodium) for chickens for fattening, chickens reared for laying and turkeys
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof8compoundsbelongingtodifferentchemicalgroupswhenusedasflavouringsforcatsanddogs
‡A
Safety and efficacy of eight compounds belonging to different chemical groups when used as flavourings for cats and dogs
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofeconasextendo14βxylanaseasafeedadditiveforpigsforfattening
‡A
Safety and efficacy of ECONASE® XT (endo-1,4-β-xylanase) as a feed additive for pigs for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofeconasextendo14βxylanaseasafeedadditiveforlayinghens
‡A
Safety and efficacy of ECONASE® XT (endo-1,4-β-xylanase) as a feed additive for laying hens
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofeb1510bacillussubtilisdsm25841asafeedadditiveforweanedpigletsandminorporcinespecies
‡A
Safety and efficacy of EB15 10 (Bacillus subtilis DSM 25841) as a feed additive for weaned piglets and minor porcine species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofeb1510bacillussubtilisdsm25841asafeedadditiveforpigletssucklingandweanedpigsforfatteningsowsinordertohavebenefitsinpigletssowsforreproductionandminorporcinespecies
‡A
Safety and efficacy of EB15 10 (Bacillus subtilis DSM 25841) as a feed additive for piglets (suckling and weaned), pigs for fattening, sows in order to have benefits in piglets, sows for reproduction and minor porcine species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofdspna2edtatanninrichextractofcastaneasativathymeoilandoriganumoilforpigsforfattening
‡A
Safety and efficacy of DSP® (Na2EDTA, tannin-rich extract of Castanea sativa, thyme oil and origanum oil) for pigs for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofdrygrapeextract6020whenusedasfeedflavouringfordogs
‡A
Safety and efficacy of 'dry grape extract 60-20' when used as feed flavouring for dogs
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofdeccoxdecoquinateforchickensforfattening
‡A
Safety and efficacy of Deccox® (decoquinate) for chickens for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcumintincturecuminumcyminum50whenusedasasensoryadditiveforallanimalspecies
‡A
Safety and efficacy of cumin tincture (Cuminum cyminum L.) when used as a sensory additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcoxirildiclazurilforpheasants
‡A
Safety and efficacy of Coxiril® (diclazuril) for pheasants
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcoxirildiclazurilforchickensrearedforlaying
‡A
Safety and efficacy of Coxiril® (diclazuril) for chickens reared for laying
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcoxarnicarbazinforturkeysforfattening
‡A
Safety and efficacy of Coxar® (nicarbazin) for turkeys for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcoxamamproliumhydrochlorideforchickensforfatteningandchickensrearedforlaying
‡A
Safety and efficacy of COXAM® (amprolium hydrochloride) for chickens for fattening and chickens reared for laying
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcorrelinktmabs747bacillussubtilisbacillusvelezensisnrrlb67257asafeedadditiveforallgrowingpoultryspecies
‡A
Safety and efficacy of Correlink™ ABS747 Bacillus subtilis (Bacillus velezensis NRRL B-67257) as a feed additive for all growing poultry species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcorrelinktmabs1781bacillussubtilisbacillusvelezensisnrrlb67259asafeedadditiveforallgrowingpoultryspecies
‡A
Safety and efficacy of Correlink™ ABS1781 Bacillus subtilis (Bacillus velezensisNRRL B-67259) as a feed additive for all growing poultry species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcorrelinka¢abs747bacillussubtilisbacillusvelezensisnrrlb67257asafeedadditiveforallgrowingpoultryspecies
‡A
Safety and efficacy of Correlinkâ„¢ ABS747 Bacillus subtilis (Bacillus velezensis NRRL B-67257) as a feed additive for all growing poultry species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcorrelinka¢abs1781bacillussubtilisbacillusvelezensisnrrlb67259asafeedadditiveforallgrowingpoultryspecies
‡A
Safety and efficacy of Correlinkâ„¢ ABS1781 Bacillus subtilis (Bacillus velezensisNRRL B-67259) as a feed additive for all growing poultry species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcopperchelatesoflysineandglutamicacidasafeedadditiveforallanimalspecies
‡A
Safety and efficacy of copper chelates of lysine and glutamic acid as a feed additive for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofconcentratedliquid50lysinebaseand50lysinemonohydrochlorideproducedbyfermentationwithcorynebacteriumcaseikccm80190asfeedadditivesforallanimalspecies
‡A
Safety and efficacy of concentrated liquid l-lysine (base) and l-lysine monohydrochloride produced by fermentation with Corynebacterium casei KCCM 80190 as feed additives for all animal species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcisnorbixin501potassiumsaltannattofforcatsanddogs
‡A
Safety and efficacy of cis‐norbixin di‐potassium salt (annatto F) for cats and dogs
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcisnorbixin501potassiumsalt
‡A
Safety and efficacy of cis‐norbixin di‐potassium salt
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcinergylifeb3hiconbacillusamyloliquefaciensnrrlb50508bamyloliquefaciensnrrlb50509andbacillussubtilisnrrlb50510asafeedadditiveforpigsforfatteningandminorporcinespecies
‡A
Safety and efficacy of Cinergy® Life B3 HiCon (Bacillus amyloliquefaciens NRRL B-50508, B. amyloliquefaciens NRRL B-50509 and Bacillus subtilis NRRL B-50510) as a feed additive for pigs for fattening and minor porcine species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyof101fertmferriccitratechelateasazootechnicalfeedadditiveforsucklingandweanedpigletsandminorporcinespecies
‡A
Safety and efficacy of CI-FER™ (ferric citrate chelate) as a zootechnical feed additive for suckling and weaned piglets and minor porcine species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcapsozymesbplusαgalactosidaseandendo14βxylanaseasafeedadditiveforpoultryspeciesforfatteningorrearedforlayingandornamentalbirds
‡A
Safety and efficacy of Capsozyme SB Plus (α-galactosidase and endo-1,4-β-xylanase) as a feed additive for poultry species for fattening or reared for laying and ornamental birds
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcalsporinbacillussubtilisdsm15544forsowsandsucklingpiglets
‡A
Safety and efficacy of Calsporin® (Bacillus subtilis DSM 15544) for sows and suckling piglets
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcalsporinbacillussubtilisdsm15544forallpoultryspecies
‡A
Safety and efficacy of Calsporin® (Bacillus subtilis DSM 15544) for all poultry species
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcalsporinbacillussubtilisdsm15544asafeedadditiveforpigsforfattening
‡A
Safety and efficacy of Calsporin® (Bacillus subtilis DSM 15544) as a feed additive for pigs for fattening
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofcalsporinbacillussubtilisdsm15544asafeedadditivefordogs
‡A
Safety and efficacy of Calsporin® (Bacillus subtilis DSM 15544) as a feed additive for dogs
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
PTBNP|40731
|
|
996
|
|
|
‡2
BLBNB|000443657
|
|
996
|
|
|
‡2
ISNI|0000000027199989
|
|
996
|
|
|
‡2
BNF|13573929
|
|
996
|
|
|
‡2
LC|n 90675051
|
|
996
|
|
|
‡2
PTBNP|1157083
|
|
996
|
|
|
‡2
PTBNP|1823558
|
|
996
|
|
|
‡2
BLBNB|001128548
|
|
996
|
|
|
‡2
DNB|1057169404
|
|
996
|
|
|
‡2
PTBNP|63857
|
|
996
|
|
|
‡2
PTBNP|1342938
|
|
996
|
|
|
‡2
ISNI|0000000373490357
|
|
996
|
|
|
‡2
ISNI|0000000025239860
|
|
996
|
|
|
‡2
BLBNB|000610362
|
|
996
|
|
|
‡2
DNB|1079303987
|
|
996
|
|
|
‡2
BLBNB|000610369
|
|
996
|
|
|
‡2
DNB|1056636521
|
|
996
|
|
|
‡2
NII|DA09054927
|
|
996
|
|
|
‡2
ISNI|0000000070236597
|
|
996
|
|
|
‡2
BLBNB|000489288
|
|
996
|
|
|
‡2
BLBNB|001503102
|
|
996
|
|
|
‡2
PTBNP|254140
|
|
996
|
|
|
‡2
PLWABN|9810680650405606
|
|
996
|
|
|
‡2
PTBNP|253196
|
|
996
|
|
|
‡2
ISNI|0000000068394123
|
|
996
|
|
|
‡2
LC|n 84101395
|
|
996
|
|
|
‡2
PTBNP|1449994
|
|
996
|
|
|
‡2
PTBNP|905547
|
|
996
|
|
|
‡2
BNE|XX1643571
|
|
996
|
|
|
‡2
BLBNB|000610354
|
|
996
|
|
|
‡2
DNB|1245965972
|
|
996
|
|
|
‡2
BNF|12674118
|
|
996
|
|
|
‡2
SUDOC|109380002
|
|
996
|
|
|
‡2
BLBNB|000213039
|
|
996
|
|
|
‡2
LC|no2003107275
|
|
996
|
|
|
‡2
PTBNP|255598
|
|
996
|
|
|
‡2
PTBNP|1185411
|
|
996
|
|
|
‡2
LC|nr 92025036
|
|
996
|
|
|
‡2
PTBNP|1484496
|
|
996
|
|
|
‡2
ISNI|0000000049385774
|
|
996
|
|
|
‡2
PTBNP|1718845
|
|
996
|
|
|
‡2
SUDOC|031965768
|
|
996
|
|
|
‡2
BLBNB|000610359
|
|
996
|
|
|
‡2
PTBNP|104727
|
|
996
|
|
|
‡2
LC|ns2023000370
|
|
996
|
|
|
‡2
SUDOC|154810800
|
|
996
|
|
|
‡2
LC|no2007014493
|
|
996
|
|
|
‡2
PTBNP|1818609
|
|
996
|
|
|
‡2
SUDOC|154769371
|
|
996
|
|
|
‡2
ISNI|0000000053359747
|
|
996
|
|
|
‡2
BLBNB|000289800
|
|
996
|
|
|
‡2
BLBNB|000425199
|
|
996
|
|
|
‡2
PTBNP|1276883
|
|
996
|
|
|
‡2
DNB|105727335X
|
|
996
|
|
|
‡2
SUDOC|159723639
|
|
996
|
|
|
‡2
DNB|1057043818
|
|
996
|
|
|
‡2
NUKAT|n 2009154874
|
|
996
|
|
|
‡2
BNE|XX1183764
|
|
996
|
|
|
‡2
ISNI|000000035939887X
|
|
996
|
|
|
‡2
ISNI|0000000033827275
|
|
996
|
|
|
‡2
SUDOC|281166234
|
|
996
|
|
|
‡2
BLBNB|000256106
|
|
996
|
|
|
‡2
LC|no2003126733
|
|
996
|
|
|
‡2
BLBNB|000455128
|
|
996
|
|
|
‡2
LC|no 00023411
|
|
996
|
|
|
‡2
NTA|303294922
|
|
996
|
|
|
‡2
SUDOC|17810678X
|
|
996
|
|
|
‡2
CAOONL|ncf11428691
|
|
996
|
|
|
‡2
ISNI|000000006921469X
|
|
996
|
|
|
‡2
SUDOC|110188942
|
|
996
|
|
|
‡2
ISNI|0000000081559711
|
|
996
|
|
|
‡2
ISNI|0000000026807532
|
|
996
|
|
|
‡2
ISNI|000000006898449X
|
|
996
|
|
|
‡2
BNF|12517070
|
|
996
|
|
|
‡2
ISNI|0000000069790486
|
|
996
|
|
|
‡2
ISNI|0000000428282118
|
|
996
|
|
|
‡2
NUKAT|n 2018246150
|
|
996
|
|
|
‡2
NTA|072159405
|
|
996
|
|
|
‡2
ISNI|0000000068203673
|
|
996
|
|
|
‡2
ISNI|0000000070805235
|
|
996
|
|
|
‡2
ISNI|0000000366824339
|
|
996
|
|
|
‡2
PTBNP|1170340
|
|
996
|
|
|
‡2
PTBNP|1903916
|
|
996
|
|
|
‡2
DNB|127392122
|
|
996
|
|
|
‡2
PTBNP|2065
|
|
996
|
|
|
‡2
PTBNP|211321
|
|
996
|
|
|
‡2
PTBNP|1211650
|
|
996
|
|
|
‡2
SUDOC|224570110
|
|
996
|
|
|
‡2
LC|n 2007214136
|
|
996
|
|
|
‡2
J9U|987007445071005171
|
|
996
|
|
|
‡2
ISNI|0000000070998989
|
|
996
|
|
|
‡2
DNB|1061342719
|
|
996
|
|
|
‡2
RERO|A018446645
|
|
996
|
|
|
‡2
ISNI|0000000070840911
|
|
996
|
|
|
‡2
ISNI|0000000039566854
|
|
996
|
|
|
‡2
LC|n 2023067616
|
|
996
|
|
|
‡2
BLBNB|000532151
|
|
996
|
|
|
‡2
ISNI|0000000049044670
|
|
996
|
|
|
‡2
SUDOC|069295980
|
|
996
|
|
|
‡2
LC|no2023063366
|
|
996
|
|
|
‡2
PTBNP|948973
|
|
996
|
|
|
‡2
J9U|987007426297405171
|
|
996
|
|
|
‡2
NII|DA1678697X
|
|
996
|
|
|
‡2
LC|no 00076337
|
|
996
|
|
|
‡2
DNB|1052075940
|
|
996
|
|
|
‡2
PTBNP|231075
|
|
996
|
|
|
‡2
CAOONL|ncf11477094
|
|
996
|
|
|
‡2
BNF|12308478
|
|
996
|
|
|
‡2
SUDOC|034412646
|
|
996
|
|
|
‡2
BLBNB|000573791
|
|
996
|
|
|
‡2
ISNI|0000000033155210
|
|
996
|
|
|
‡2
PTBNP|124031
|
|
996
|
|
|
‡2
ISNI|0000000068789125
|
|
996
|
|
|
‡2
ISNI|0000000029465355
|
|
996
|
|
|
‡2
BIBSYS|4060334
|
|
996
|
|
|
‡2
BLBNB|001022886
|
|
996
|
|
|
‡2
ISNI|000000006929655X
|
|
996
|
|
|
‡2
DNB|1056519495
|
|
996
|
|
|
‡2
LC|n 2015236331
|
|
996
|
|
|
‡2
ISNI|0000000044947598
|
|
996
|
|
|
‡2
BLBNB|000548936
|
|
996
|
|
|
‡2
LC|no2023020572
|
|
996
|
|
|
‡2
SUDOC|272823244
|
|
996
|
|
|
‡2
DNB|1056376643
|
|
996
|
|
|
‡2
ISNI|0000000070211621
|
|
996
|
|
|
‡2
PTBNP|489449
|
|
996
|
|
|
‡2
ISNI|000000007022932X
|
|
996
|
|
|
‡2
BNF|16593242
|
|
996
|
|
|
‡2
PTBNP|1385397
|
|
996
|
|
|
‡2
BNF|13492602
|
|
996
|
|
|
‡2
PTBNP|136852
|
|
996
|
|
|
‡2
ISNI|0000000082694472
|
|
996
|
|
|
‡2
LC|n 88041731
|
|
996
|
|
|
‡2
ISNI|000000007282670X
|
|
996
|
|
|
‡2
PTBNP|13691
|
|
996
|
|
|
‡2
DNB|1060697661
|
|
996
|
|
|
‡2
ISNI|0000000116076315
|
|
996
|
|
|
‡2
CAOONL|ncf11479523
|
|
996
|
|
|
‡2
ISNI|0000000068316168
|
|
996
|
|
|
‡2
ISNI|0000000069089040
|
|
996
|
|
|
‡2
ISNI|0000000067970328
|
|
996
|
|
|
‡2
LC|no2001012769
|
|
996
|
|
|
‡2
RERO|A002975614
|
|
996
|
|
|
‡2
ISNI|000000007041332X
|
|
996
|
|
|
‡2
LC|n 2021252016
|
|
996
|
|
|
‡2
LC|n 92009706
|
|
996
|
|
|
‡2
LC|no2020146715
|
|
996
|
|
|
‡2
PTBNP|114384
|
|
996
|
|
|
‡2
BLBNB|000733286
|
|
996
|
|
|
‡2
SUDOC|050268384
|
|
996
|
|
|
‡2
NTA|393754499
|
|
996
|
|
|
‡2
BLBNB|000986358
|
|
996
|
|
|
‡2
BLBNB|000610375
|
|
996
|
|
|
‡2
PTBNP|1373677
|
|
996
|
|
|
‡2
BLBNB|000177421
|
|
996
|
|
|
‡2
SZ|1052075940
|
|
996
|
|
|
‡2
ISNI|0000000036448860
|
|
996
|
|
|
‡2
PTBNP|1012249
|
|
996
|
|
|
‡2
ISNI|0000000452606573
|
|
996
|
|
|
‡2
NII|DA06870504
|
|
996
|
|
|
‡2
BLBNB|000265804
|
|
996
|
|
|
‡2
ISNI|0000000118713365
|
|
996
|
|
|
‡2
LC|n 86124842
|
|
996
|
|
|
‡2
BLBNB|000439375
|
|
996
|
|
|
‡2
DNB|1155527771
|
|
996
|
|
|
‡2
BLBNB|000373859
|
|
996
|
|
|
‡2
BLBNB|001580453
|
|
996
|
|
|
‡2
BLBNB|000610383
|
|
996
|
|
|
‡2
RERO|A014115831
|
|
996
|
|
|
‡2
BLBNB|000274222
|
|
996
|
|
|
‡2
BLBNB|000583528
|
|
996
|
|
|
‡2
RERO|A020036342
|
|
996
|
|
|
‡2
J9U|987007340090505171
|
|
996
|
|
|
‡2
NII|DA07812886
|
|
996
|
|
|
‡2
LC|n 80158686
|
|
996
|
|
|
‡2
RERO|A024588921
|
|
996
|
|
|
‡2
LC|nb2008009390
|
|
996
|
|
|
‡2
ISNI|0000000070627459
|
|
996
|
|
|
‡2
ISNI|0000000070107410
|
|
996
|
|
|
‡2
BLBNB|000246223
|
|
996
|
|
|
‡2
ISNI|0000000115982834
|
|
996
|
|
|
‡2
BIBSYS|90895654
|
|
996
|
|
|
‡2
DNB|170309282
|
|
996
|
|
|
‡2
ISNI|0000000081383509
|
|
996
|
|
|
‡2
DNB|1220873535
|
|
996
|
|
|
‡2
ISNI|0000000113890784
|
|
996
|
|
|
‡2
NTA|13691036X
|
|
996
|
|
|
‡2
PTBNP|1922527
|
|
996
|
|
|
‡2
BLBNB|001026516
|
|
996
|
|
|
‡2
PTBNP|1493834
|
|
996
|
|
|
‡2
ISNI|0000000069220432
|
|
996
|
|
|
‡2
ISNI|0000000450733632
|
|
996
|
|
|
‡2
PTBNP|943699
|
|
996
|
|
|
‡2
DNB|1328249719
|
|
996
|
|
|
‡2
PTBNP|1762333
|
|
996
|
|
|
‡2
RERO|A002975616
|
|
996
|
|
|
‡2
SUDOC|183165977
|
|
996
|
|
|
‡2
BLBNB|001114725
|
|
996
|
|
|
‡2
SUDOC|075047896
|
|
996
|
|
|
‡2
DNB|133992411
|
|
996
|
|
|
‡2
ISNI|0000000021707938
|
|
996
|
|
|
‡2
LC|n 2013001448
|
|
996
|
|
|
‡2
BLBNB|000610372
|
|
996
|
|
|
‡2
ISNI|0000000399687430
|
|
996
|
|
|
‡2
LC|n 89147269
|
|
996
|
|
|
‡2
LC|no2012012514
|
|
996
|
|
|
‡2
ISNI|0000000068912250
|
|
996
|
|
|
‡2
ISNI|0000000029980293
|
|
996
|
|
|
‡2
LC|n 90624924
|
|
996
|
|
|
‡2
BLBNB|000616367
|
|
996
|
|
|
‡2
BIBSYS|90733667
|
|
996
|
|
|
‡2
PTBNP|1727849
|
|
996
|
|
|
‡2
PTBNP|1755693
|
|
996
|
|
|
‡2
ISNI|0000000428335080
|
|
996
|
|
|
‡2
LC|nr 94029230
|
|
996
|
|
|
‡2
PTBNP|1427886
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
|
998
|
|
|
‡a
Bastos, Maria de Lurdes A.
‡2
ISNI|0000000068203673
‡3
suggested
|
|
998
|
|
|
‡a
Bastos,
‡b
Maria de Lurdes A.
‡2
PTBNP|240787
‡3
title: (0.84, 'invitrotoxicityevaluationofpiperazinedesignerdrugs', 'invitroneurotoxicityevaluationofpiperazinedesignerdrugsindifferentiatedhumanneuroblastomashsy5ycells')
|
